rfhg_105376.1

Basic information about the TSS

---

TSS ID: rfhg_105376.1 TSS ID(Version3): hg_92601.1 hg_92605.1 hg_92604.1 hg_92603.1 hg_92602.1 Species: human Chr: chr8		Start: 30082863 End: 30083126 Strand: -
Source datasets	FANTOM5|PRJDB5282|PRJNA615891|PRJNA401781|PRJNA548673 |PRJNA597322|PRJNA4843412|DRA013844
Protocol	CAGE|C1CAGE|TIF-seq2|RAMPAGE|oligo_capping|ReCappable-seq |STRIPE-seq|NETCAGE|SLIC_CAGE
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4077845,EH38E2621746)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000256255.11:0 ENST00000518174.5:0 ENST00000521265.5:0 ENST00000518340.1:0 ENST00000522055.1:0 ENST00000523761.1:0 ENST00000517569.1:0 ENST00000521083.1:0 BC015012:0 AB028926:0 AF100748:0 AF078855:0 JQ348891:0 AK075340:0 AK025927:0 AK295360:0 AK222632:0 AK315956:0 AY454545:0 AF490252:0 JQ348892:0 AK314659:0 Z70223:0 GeneID: 51669 HGNC/MGI_ID: HGNC:28789 UniProt_ID: A0A140VK59 B7Z307 E5RFJ9 E5RJG8 E5RJV6 E5RK07 H0YBH7 Nearer transcript ids and distances: AY359104:-7 HM005599:-7 AK094386:-17 ENST00000520303.5:-27 ENST00000545648.2:-82 NM_001284239.1:-82 ENST00000522794.1:439 view more...

Gene_name: store-operated calcium entry associated regulatory factor Gene_symbol: SARAF Gene_synonyms: MGC8721 Gene_source: HGNC:28789

TATA-Box annotation

---

Distance to TSS:	70
Nearest PromoterID:	NM_016127
Entrez ID:	51669
Nearest Unigene:	Hs.521487
Nearest Refseq:	NM_016127
Nearest Ensembl:	ENSG00000133872
Gene Name:	store-operated calcium entry associated regulatory factor
Gene Alias:	FOAP-7|HSPC035|TMEM66|XTP3
Gene Type:	protein-coding
CpG%:	0.129278
GC%:	0.712121
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SARAF p2@SARAF p3@SARAF p4@SARAF p5@SARAF p6@SARAF p7@SARAF p8@SARAF p9@SARAF p10@SARAF
Sample		p1@SARAF	p2@SARAF	p3@SARAF	p4@SARAF	p5@SARAF	p6@SARAF	p7@SARAF	p8@SARAF	p9@SARAF	p10@SARAF
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	103.83	11.88	3.31	3.51	1.56	1.36	0.58	0.19	0.00	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	112.08	10.12	2.63	3.03	1.62	0.40	1.01	0.20	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	105.33	12.35	2.12	2.12	1.93	0.58	0.96	1.74	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	101.67	10.60	2.91	2.49	0.83	0.83	0.62	0.62	0.42	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	101.23	8.77	2.47	2.92	1.80	0.67	0.45	0.45	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	89.73	10.85	1.55	1.55	1.36	0.39	0.39	0.97	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	122.89	13.73	2.83	4.79	3.27	0.22	0.44	0.87	0.44	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	90.11	10.90	2.42	2.66	0.97	0.97	0.48	0.24	0.48	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	111.35	13.89	2.78	3.21	1.71	0.85	0.43	0.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	76.51	23.76	4.64	1.74	1.74	0.58	0.58	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	85.70	21.83	2.02	3.64	3.23	0.81	0.40	0.81	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	88.63	15.86	2.85	4.47	2.03	0.00	0.41	0.81	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	155.39	7.90	7.41	0.81	2.42	1.13	0.64	1.61	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	116.52	9.62	3.61	0.90	1.95	0.75	1.35	1.20	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	142.93	9.22	8.12	1.32	3.51	0.88	1.32	1.32	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	134.55	7.80	8.30	1.76	1.51	0.75	1.26	1.26	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	124.27	8.30	5.90	1.53	3.28	1.97	1.75	0.44	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	94.49	7.17	7.17	0.42	1.27	1.27	0.84	1.27	1.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	113.56	6.40	6.40	1.07	1.07	1.60	0.53	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	136.15	7.22	6.17	1.35	1.81	0.90	1.20	0.45	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	133.52	7.35	6.15	2.14	2.27	1.74	0.94	0.67	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	122.39	6.90	5.18	0.86	1.04	0.86	1.73	0.69	0.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	120.08	7.88	7.24	1.55	1.29	1.55	0.78	1.55	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	125.70	8.49	8.49	1.21	1.21	2.67	0.49	0.97	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	146.02	8.00	6.45	2.06	2.06	1.29	0.77	1.29	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	118.06	6.01	7.28	1.58	1.90	1.27	1.90	0.00	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	118.13	6.59	7.14	0.00	2.20	4.40	1.65	1.65	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	137.92	6.60	8.02	2.12	1.65	0.94	1.65	2.59	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	117.75	6.46	4.52	1.62	1.94	0.97	0.48	1.45	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	139.71	7.78	5.61	1.99	2.90	1.27	0.72	1.09	0.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	127.28	7.12	5.44	1.88	2.72	1.67	1.26	0.63	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	129.93	9.57	5.67	1.37	2.54	1.76	0.98	1.17	0.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	121.76	8.02	8.02	0.84	2.32	1.27	1.48	0.84	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	119.75	7.26	6.60	0.82	3.46	2.14	2.47	2.14	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	136.69	7.11	9.54	0.93	2.24	0.75	2.06	1.31	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	141.61	7.86	9.20	2.49	2.49	0.96	1.53	0.38	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	125.90	6.54	6.13	2.25	1.23	2.04	0.20	1.43	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	120.29	7.66	5.24	1.01	3.22	0.60	1.61	1.81	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	137.75	7.29	7.02	0.54	2.16	2.97	1.08	0.54	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	126.27	6.24	7.44	1.68	1.92	0.48	2.16	0.48	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	121.63	7.76	4.71	1.41	2.35	1.65	0.94	1.18	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	108.04	7.91	5.56	1.32	2.20	1.32	1.76	1.17	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	156.90	8.65	7.17	1.27	1.69	2.11	1.27	0.63	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	135.32	7.52	7.17	1.22	2.10	2.27	1.05	1.05	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	138.53	6.83	7.03	2.01	2.61	0.80	1.61	1.20	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	132.61	9.54	8.84	1.63	2.79	1.40	1.16	2.56	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	156.42	7.20	5.52	2.88	1.92	1.68	2.16	0.48	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	133.82	11.92	3.58	2.09	3.28	1.79	0.89	1.49	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	156.55	9.34	9.10	3.11	2.87	0.72	2.15	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	141.13	7.28	8.69	0.40	1.62	1.42	1.42	1.21	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	114.57	9.43	7.79	1.84	3.89	1.23	1.02	2.25	1.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	152.10	11.56	8.45	2.22	3.78	1.33	1.33	3.11	1.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	195.89	41.98	13.99	0.00	0.00	0.00	0.00	27.98	41.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	171.40	9.58	7.10	2.84	2.48	0.71	1.06	1.42	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	155.42	11.27	7.62	3.65	3.31	0.99	0.66	1.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	96.48	5.87	7.55	3.36	1.68	0.84	3.36	10.07	6.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	103.79	9.18	7.35	1.84	2.30	2.30	2.30	2.30	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	199.97	11.34	9.08	2.59	6.16	2.92	0.65	1.62	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	221.29	12.53	12.20	2.89	7.39	1.61	0.96	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	98.39	8.80	7.54	2.20	1.57	1.26	3.46	2.51	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	217.86	4.94	8.46	3.53	7.76	0.00	2.12	2.82	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	194.59	8.97	13.46	4.49	2.80	0.56	1.12	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	66.88	9.55	3.18	2.39	2.39	0.80	3.18	6.37	6.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	94.46	6.80	5.44	2.38	1.70	2.38	0.00	1.36	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	247.91	11.37	11.37	1.30	5.52	2.27	0.97	0.97	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	209.08	12.07	12.07	1.06	5.68	1.06	1.06	0.71	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	145.48	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	134.26	31.59	15.79	7.90	7.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	180.38	10.24	13.16	1.46	3.41	2.44	0.49	0.98	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	168.10	6.45	12.89	3.47	1.98	0.50	0.50	0.99	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	128.54	6.10	15.48	2.81	3.75	0.47	0.00	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	140.42	11.59	5.96	0.99	4.31	0.33	0.33	0.66	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	255.52	10.21	13.92	0.62	5.88	0.62	1.24	1.55	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	275.78	12.54	15.59	2.45	6.42	1.53	0.31	0.92	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	142.70	8.24	9.50	3.17	4.43	0.48	1.43	1.11	1.11	0.00
Adipocyte - breast, donor2	11327-117E4	121.28	6.74	5.13	1.44	3.69	0.64	0.80	3.85	2.25	0.00
Adipocyte - omental, donor1	11473-119C6	150.26	10.31	8.52	3.05	2.80	1.40	1.78	0.51	0.76	0.00
Adipocyte - omental, donor2	11474-119C7	148.75	10.46	5.23	2.99	3.74	1.49	0.00	2.24	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	131.96	8.04	3.01	2.01	3.35	2.01	0.67	0.33	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	200.97	8.29	7.66	2.55	1.28	1.91	1.28	2.55	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	70.37	4.40	3.30	1.10	2.20	1.10	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	71.81	2.71	3.61	3.16	0.45	0.90	2.26	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	75.94	5.39	2.95	0.00	0.70	0.35	0.52	0.52	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	162.72	10.17	7.43	2.74	5.08	1.37	1.17	0.59	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	133.32	6.43	5.92	1.80	2.83	1.80	0.00	0.51	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	144.13	6.97	4.74	1.39	2.79	2.23	1.12	0.56	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	138.72	8.23	7.64	2.94	2.94	0.00	1.18	0.59	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	139.95	5.79	3.94	3.38	3.38	0.80	0.80	0.24	0.32	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	144.59	7.42	7.42	0.97	3.23	0.65	0.97	0.97	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	109.30	6.40	5.33	0.00	2.13	1.60	1.60	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	156.36	5.56	7.23	2.23	2.78	1.67	1.67	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	193.81	11.64	4.16	7.07	4.99	1.66	0.42	0.42	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	131.36	6.28	3.77	2.01	4.02	1.51	0.50	0.75	0.75	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	126.97	7.53	3.93	3.60	4.25	0.98	0.98	0.33	0.98	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	129.70	4.87	3.65	2.74	3.04	0.30	0.00	0.91	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	50.83	2.43	3.31	1.77	1.33	0.00	0.00	0.44	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	16.85	0.36	0.36	0.36	0.00	0.00	0.36	0.36	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	23.96	1.20	3.59	0.00	2.40	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	100.93	9.71	5.76	3.24	1.08	0.54	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	93.72	6.69	3.35	5.02	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	97.79	6.57	6.16	2.26	1.85	0.62	0.21	0.62	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	73.00	7.09	7.09	2.17	2.75	0.69	0.11	0.23	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	98.70	7.84	8.08	1.22	1.71	0.00	0.24	0.49	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	114.57	4.04	3.59	1.80	2.70	1.35	1.35	1.35	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	112.88	4.34	3.47	3.04	3.47	0.00	0.43	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	149.82	2.14	6.42	0.00	2.14	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	100.14	8.07	2.99	1.79	2.39	2.39	0.30	0.90	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	93.58	2.53	3.79	0.00	6.32	3.79	0.00	2.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	121.45	5.94	3.96	1.98	2.64	0.00	0.00	1.32	1.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	105.26	2.27	1.30	3.90	1.30	0.00	0.00	1.62	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	98.06	9.71	4.85	1.46	0.97	0.49	0.00	0.97	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	105.71	7.13	4.75	2.38	0.59	0.00	2.38	0.59	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	105.84	6.78	1.88	1.88	1.51	1.13	0.00	1.13	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	117.56	2.18	4.35	1.45	0.73	3.63	0.73	1.45	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	141.68	6.27	5.02	1.25	5.02	1.25	1.25	5.02	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	141.51	10.54	6.75	3.13	4.45	0.66	0.16	0.33	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	109.18	6.82	1.36	2.73	0.00	1.36	0.00	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	166.62	9.95	8.90	3.17	5.58	0.15	0.30	1.21	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	110.37	4.29	3.75	1.61	1.61	2.14	0.00	1.07	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	115.82	5.48	2.83	1.70	5.29	0.94	0.57	0.94	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	116.27	5.88	6.95	2.41	3.47	0.80	0.53	2.41	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	99.50	7.80	4.88	2.93	1.95	0.00	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	110.13	4.98	5.14	2.16	2.32	0.33	0.00	1.00	1.16	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	109.27	4.80	4.80	2.40	4.80	1.20	2.40	6.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	123.91	0.00	7.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	108.92	6.69	3.60	2.57	2.40	0.69	0.34	0.86	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	121.65	0.00	12.58	0.00	8.39	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	115.53	4.85	2.43	3.88	2.91	0.97	0.49	1.94	1.46	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	113.84	7.97	3.42	3.04	3.42	1.52	0.38	1.52	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	138.10	4.85	6.06	2.42	1.21	1.21	1.21	3.63	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	107.74	7.98	4.56	2.28	1.14	1.71	0.00	2.85	1.71	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	118.86	3.42	5.56	3.21	3.21	0.86	0.64	1.28	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	126.21	6.45	6.97	3.10	2.84	0.77	0.00	0.77	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	98.53	5.63	4.22	0.47	4.22	0.94	0.47	2.35	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	110.61	5.79	5.14	1.61	2.57	0.96	0.32	2.25	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	122.71	4.99	3.57	1.43	3.57	0.00	0.00	1.43	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	101.78	8.77	3.51	3.51	2.92	0.00	0.00	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	122.54	4.52	5.72	2.71	1.51	0.30	0.60	1.20	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	130.68	7.13	10.69	1.19	1.19	4.75	1.19	2.38	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	98.66	7.63	4.58	3.56	2.03	1.53	0.00	2.03	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	105.44	4.84	5.86	3.82	1.78	1.78	0.51	1.27	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	124.53	5.08	6.99	5.72	3.18	0.64	0.64	1.91	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	113.92	6.04	4.32	3.45	1.29	0.43	0.43	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	100.55	7.41	4.87	2.33	2.96	1.06	0.64	0.85	0.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	116.57	7.83	5.51	2.32	4.35	0.29	0.00	1.16	0.87	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	110.53	8.50	4.72	4.72	2.83	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	110.19	5.93	4.75	2.20	2.88	0.85	0.51	0.34	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	120.45	2.32	6.95	2.32	0.00	0.00	0.00	2.32	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	139.43	2.11	4.23	0.00	4.23	0.00	0.00	2.11	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	110.85	5.57	5.36	3.00	4.93	0.43	0.43	1.07	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	125.15	7.82	5.41	4.81	3.01	0.60	0.00	1.20	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	96.22	6.56	4.37	4.37	0.73	0.00	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	107.12	5.06	3.68	2.53	2.07	0.00	0.23	0.69	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	99.46	5.10	2.55	5.10	7.65	0.00	5.10	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	197.28	9.41	10.93	2.80	9.15	0.25	0.51	0.76	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	114.16	7.02	5.57	2.89	2.68	0.83	0.41	1.24	0.83	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	131.27	7.04	5.81	3.06	3.67	0.61	0.31	1.22	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	129.54	4.78	4.78	2.39	0.48	1.43	0.96	0.48	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	111.54	7.76	4.66	2.66	2.44	0.67	0.22	1.77	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	123.59	4.58	3.05	0.00	3.05	1.53	0.00	3.05	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	106.35	9.42	7.20	1.11	1.66	0.55	0.55	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	110.15	5.83	2.91	2.38	4.24	1.06	0.53	0.26	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	127.57	5.45	4.72	2.18	3.27	1.09	0.00	1.09	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	55.64	7.25	4.42	2.95	2.21	0.00	0.25	0.00	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	50.49	5.65	4.11	3.08	2.40	0.17	0.17	0.34	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	44.26	5.45	4.40	1.05	1.05	0.21	0.21	0.42	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	122.70	14.64	12.55	4.18	2.44	0.00	0.70	0.35	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	106.45	8.09	6.96	2.26	3.07	0.32	0.16	1.29	0.49	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	121.86	8.20	10.14	1.34	1.79	0.60	0.15	0.60	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	67.09	4.59	2.87	2.87	1.03	0.00	0.23	0.57	0.23	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	63.77	6.14	4.01	2.51	1.00	0.50	0.00	0.13	0.13	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	64.30	6.37	2.62	3.07	1.02	0.11	0.34	0.11	0.00	0.11
Basophils, donor1	12241-129G9	375.56	12.29	4.18	17.00	31.65	0.78	0.26	1.31	2.09	2.35
Basophils, donor2	12242-129H1	510.52	10.46	5.41	30.31	35.72	1.80	1.08	1.80	1.08	1.80
Basophils, donor3	12243-129H2	373.52	8.53	3.53	12.94	25.14	0.44	0.29	0.15	1.03	2.20
Bronchial Epithelial Cell, donor1	11511-119G8	47.86	3.88	2.37	1.51	0.86	0.43	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	17.83	0.46	0.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	100.43	14.35	14.35	0.00	7.17	0.00	0.00	14.35	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	37.66	1.26	0.63	1.26	0.63	0.63	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	38.89	1.66	1.66	0.21	1.25	0.00	0.00	0.62	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	52.74	3.22	2.07	1.15	0.46	0.69	0.23	0.23	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	73.42	4.86	2.88	3.42	0.72	0.54	0.18	0.18	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	99.45	3.30	1.13	1.34	1.55	0.31	0.00	0.31	0.21	0.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	65.21	3.03	1.63	1.16	1.40	0.00	0.47	0.23	0.23	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	413.47	9.91	10.87	8.63	16.31	0.96	0.32	0.96	0.00	5.76
CD133+ stem cells - cord blood derived, pool1	12223-129E9	734.28	10.34	10.34	31.03	31.03	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	325.74	10.71	1.69	7.89	22.54	0.00	0.00	0.56	0.56	1.13
CD14+ Monocytes, donor2	11305-117B9	336.68	5.01	1.30	11.32	19.49	1.30	0.56	1.86	1.67	2.60
CD14+ Monocytes, donor3	11381-118B4	407.68	8.12	3.95	8.78	27.66	0.44	0.44	2.41	1.98	6.15
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	430.51	20.66	12.17	3.96	9.34	4.25	5.94	2.26	1.13	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	448.07	15.16	12.13	4.93	10.99	5.31	3.79	2.27	2.27	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	438.21	17.75	10.85	4.60	9.20	1.64	2.63	1.97	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	306.59	7.66	3.18	8.38	8.82	2.89	1.59	3.18	2.31	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	239.28	5.73	2.72	6.94	7.24	1.21	1.51	2.72	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	319.81	7.34	2.37	10.42	12.79	1.18	1.42	2.13	1.66	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	227.66	7.87	2.34	5.19	6.19	1.00	0.84	1.17	1.34	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	208.94	3.86	0.83	4.14	6.35	0.55	0.00	1.66	1.38	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	235.53	4.46	2.48	5.21	9.67	0.25	1.24	1.24	1.24	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	199.52	4.50	0.78	4.11	5.48	0.20	0.20	1.76	0.59	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	219.89	4.63	2.49	4.81	6.23	1.07	0.53	1.25	0.89	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	335.59	8.92	3.48	10.45	11.75	1.52	0.65	3.05	1.31	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	242.56	8.43	3.04	6.56	8.19	1.87	3.75	0.47	1.40	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	284.61	6.34	2.11	7.39	12.14	2.64	5.28	2.64	1.58	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	328.37	9.98	0.00	6.66	9.98	4.44	5.55	3.33	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	253.17	7.14	2.53	6.99	8.63	1.34	3.12	3.57	1.64	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	235.87	5.79	1.40	3.99	8.38	1.80	2.59	1.80	0.60	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	290.23	10.20	2.91	8.54	13.53	3.12	2.71	3.96	1.25	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	273.40	7.32	4.35	9.84	7.55	3.20	8.47	2.52	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	203.13	6.79	1.58	6.79	11.08	2.49	5.88	0.90	0.90	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	267.11	6.55	1.31	7.86	14.40	4.36	6.11	0.44	2.62	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	299.65	5.65	1.88	11.03	7.80	2.15	0.81	1.61	1.34	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	329.56	8.55	2.79	6.46	9.77	1.22	1.22	2.97	1.74	1.40
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	437.65	10.94	3.79	7.15	14.73	2.95	0.42	5.89	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	186.83	5.70	1.84	4.96	5.33	1.47	0.00	1.84	1.47	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	162.04	4.23	2.11	4.58	8.81	0.35	0.35	1.06	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	164.52	4.83	1.75	7.46	3.95	0.00	0.88	1.32	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	206.11	6.45	1.92	5.23	4.71	0.70	0.52	0.87	1.39	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	194.76	6.69	1.12	2.23	7.06	1.49	0.00	2.60	1.49	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	309.96	11.42	2.59	7.98	12.29	1.51	1.08	1.08	1.51	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	203.11	5.73	2.05	4.50	3.69	0.41	0.41	0.41	1.64	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	152.76	4.87	1.39	2.32	9.74	0.23	0.46	0.46	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	209.49	9.74	2.09	8.12	9.05	0.70	0.00	2.78	1.39	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	335.23	6.10	3.49	27.90	18.53	1.96	1.31	3.49	1.09	3.49
CD14+CD16+ Monocytes, donor2	11801-124D1	349.49	9.24	3.93	12.94	16.40	2.08	2.08	2.08	1.15	2.31
CD14+CD16+ Monocytes, donor3	11912-125G4	328.39	9.96	5.42	12.35	18.63	3.25	0.87	1.95	0.65	2.82
CD14+CD16- Monocytes, donor1	11788-124B6	429.48	11.52	8.10	21.65	16.04	3.27	1.40	4.05	0.31	2.49
CD14+CD16- Monocytes, donor2	11799-124C8	365.53	11.35	5.24	9.26	13.45	1.22	1.05	2.27	0.35	2.45
CD14+CD16- Monocytes, donor3	11910-125G2	288.52	12.93	6.91	9.59	16.05	1.11	1.78	0.89	0.45	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	500.91	13.27	5.10	26.79	21.95	1.28	0.26	3.06	1.28	5.61
CD14-CD16+ Monocytes, donor2	11800-124C9	460.21	11.20	5.93	14.93	23.27	3.07	0.88	3.95	2.42	4.83
CD14-CD16+ Monocytes, donor3	11911-125G3	461.52	14.95	7.37	17.05	28.84	2.32	1.26	2.53	0.42	6.74
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	554.82	12.19	12.19	28.45	20.32	4.06	2.03	4.06	0.00	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	503.06	14.92	5.42	14.92	18.98	0.68	0.68	1.36	2.03	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	559.22	12.43	12.43	21.75	20.71	2.07	2.07	1.04	1.04	4.14
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	408.84	10.66	8.53	13.86	15.46	1.60	0.53	1.60	1.07	5.33
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	532.85	10.19	5.90	17.69	20.37	0.54	1.61	3.75	0.54	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	522.24	13.34	7.72	14.04	21.06	0.70	2.11	2.11	1.40	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	541.20	11.77	9.41	15.69	12.55	2.35	0.00	0.78	2.35	4.71
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	599.82	25.05	5.27	18.46	19.77	2.64	0.00	2.64	2.64	6.59
CD19+ B Cells, donor1	11544-120B5	659.99	17.26	4.11	29.59	50.96	2.47	1.64	2.47	2.47	21.37
CD19+ B Cells, donor2	11624-122B4	521.58	6.53	5.08	26.84	46.43	2.90	1.45	2.18	2.90	9.43
CD19+ B Cells, donor3	11705-123B4	611.34	10.60	6.56	23.22	58.05	3.53	3.03	1.51	1.01	18.17
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	127.28	10.10	3.64	6.46	6.87	0.40	0.40	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	129.83	11.19	3.20	6.39	2.80	0.00	0.00	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	530.14	9.04	3.01	13.05	24.10	0.00	1.00	3.01	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	663.50	12.92	3.37	19.66	48.88	2.25	0.00	2.25	0.56	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	253.63	8.64	6.01	7.89	7.89	0.75	0.75	0.00	0.38	3.01
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	249.61	9.02	4.51	7.22	8.12	0.23	0.23	1.13	0.23	3.83
CD4+ T Cells, donor1	11225-116C1	1413.59	33.92	8.57	37.85	140.32	2.14	2.14	2.50	1.07	23.21
CD4+ T Cells, donor2	11306-117C1	1384.55	25.72	4.29	49.60	138.39	11.02	8.57	19.60	13.47	19.60
CD4+ T Cells, donor3	11382-118B5	1423.71	37.51	9.45	45.14	155.85	4.57	1.52	9.15	7.32	23.18
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	398.93	11.49	5.10	18.89	13.78	3.06	1.53	2.04	1.79	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	411.24	14.37	4.49	11.23	21.79	2.25	0.67	0.22	1.12	2.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	437.52	13.80	3.74	13.80	22.13	2.30	0.00	1.44	0.57	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	2104.49	84.86	10.43	64.48	196.27	7.11	3.32	14.22	9.01	38.88
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	2526.95	103.24	14.05	53.38	178.39	7.73	1.40	12.64	3.51	46.35
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	2119.47	108.78	26.37	42.85	161.51	3.30	6.59	13.18	9.89	46.15
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	416.93	10.69	5.06	29.77	21.39	4.05	2.75	3.18	3.03	2.46
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	295.54	11.18	5.42	8.13	16.61	1.86	0.85	2.03	1.19	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	278.56	10.48	6.29	7.25	14.67	1.13	0.64	1.61	0.48	2.74
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	1235.51	38.55	9.41	53.80	116.11	7.17	3.59	7.62	1.79	20.17
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1309.51	46.47	9.78	47.17	105.17	6.99	3.14	6.64	5.24	26.90
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	786.69	25.96	6.16	34.32	95.48	3.52	3.08	3.96	2.64	23.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	632.04	21.50	4.22	26.99	25.72	5.06	2.11	2.53	2.95	2.53
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	526.90	13.71	4.78	10.60	17.66	2.49	0.83	3.53	2.49	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	589.07	15.37	6.35	10.02	19.71	3.34	1.67	2.67	2.00	3.68
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2066.16	84.03	10.88	42.97	146.57	6.25	4.89	13.05	6.80	35.08
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	2488.95	102.90	11.25	38.05	157.57	10.72	7.50	12.86	8.04	36.44
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	2049.66	71.73	14.35	30.48	168.56	12.55	3.59	8.97	7.17	23.31
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	540.71	19.10	3.71	26.15	22.07	3.34	1.11	2.41	0.93	2.23
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	415.26	16.03	6.28	11.48	23.18	1.52	0.43	2.17	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	401.39	15.55	3.36	11.14	21.65	1.89	1.26	1.26	1.26	1.47
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1234.69	48.03	9.61	52.08	90.00	5.06	2.53	10.62	1.52	22.75
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	1582.67	43.33	13.43	40.29	116.98	7.80	1.73	8.67	4.33	23.40
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1147.07	41.40	6.97	41.40	112.88	6.54	3.49	11.33	2.18	36.17
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	1273.30	40.58	11.38	29.69	50.97	1.48	0.99	5.44	1.48	4.95
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	1209.37	36.00	6.46	35.08	41.54	5.54	0.92	3.69	5.54	6.46
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1164.12	41.87	6.98	33.50	53.04	8.37	1.40	5.58	4.19	8.37
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	1163.38	40.15	9.14	30.46	33.79	6.65	4.71	4.71	0.55	2.22
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1184.26	48.10	7.36	26.26	43.68	4.91	4.66	5.15	3.44	2.70
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	1121.12	36.96	3.08	32.34	44.66	1.54	1.54	7.70	1.54	9.24
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	990.55	35.81	8.59	34.38	36.89	2.86	2.15	4.30	2.51	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1084.45	29.08	9.69	52.63	36.01	4.15	0.00	2.77	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	882.99	21.28	5.89	48.45	89.71	2.29	3.27	2.95	0.98	19.64
CD8+ T Cells, donor2	11307-117C2	835.34	16.14	4.51	35.67	77.34	4.51	2.63	9.01	5.63	12.39
CD8+ T Cells, donor3	11383-118B6	1212.71	26.01	7.57	40.15	111.85	4.04	1.26	6.82	5.55	16.41
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	95.20	4.13	3.90	7.11	5.28	0.00	0.23	0.92	0.69	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	86.75	2.88	1.68	5.27	2.40	0.24	0.00	1.20	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	93.29	4.65	3.28	7.39	4.38	0.27	0.00	1.37	0.82	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	82.86	4.20	1.50	4.50	2.10	0.00	0.00	2.10	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	75.59	4.08	1.68	5.52	4.08	0.48	0.24	0.48	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	99.14	4.55	3.18	6.59	4.55	0.23	0.23	0.45	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	102.12	4.56	2.17	5.00	5.43	0.43	0.00	0.65	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	102.12	3.68	3.68	6.05	3.95	0.26	0.00	0.79	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	99.43	3.28	4.46	6.10	4.22	0.47	0.23	0.23	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	121.35	4.83	4.23	9.96	6.04	0.30	0.00	2.11	0.91	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	121.14	3.49	3.78	6.39	2.61	0.29	0.00	2.03	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	132.95	4.53	4.26	5.60	6.13	0.53	0.53	0.27	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	167.22	7.00	2.19	2.19	5.25	0.00	0.44	0.00	0.00	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	160.77	5.01	5.47	3.19	4.10	0.00	0.00	0.00	0.46	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	161.85	13.43	3.73	2.24	10.44	0.00	0.00	0.00	0.00	2.98
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	92.56	3.24	6.12	3.60	3.60	0.00	0.36	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	79.70	4.32	2.01	3.16	3.45	0.00	0.29	0.58	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	82.02	3.06	1.89	5.42	4.71	0.24	0.24	0.47	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	88.42	6.97	5.39	3.17	4.44	0.00	0.63	0.95	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	108.88	4.92	1.54	4.92	5.54	0.31	0.31	0.00	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	87.84	3.53	1.28	4.49	4.49	0.64	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	123.92	4.59	4.97	5.74	3.06	0.00	0.00	0.38	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	121.78	6.31	5.12	6.31	4.73	0.00	0.79	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	108.92	3.03	3.78	4.54	7.56	0.76	0.00	0.76	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	166.21	11.24	2.41	4.82	3.21	0.00	0.00	0.00	0.00	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	180.45	10.49	5.60	4.20	10.49	0.00	0.70	0.70	1.40	5.60
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	171.30	16.03	4.01	3.01	7.01	0.00	0.00	1.00	0.00	4.01
Cardiac Myocyte, donor1	11525-119I4	47.52	0.00	1.83	3.66	1.83	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	74.11	4.45	2.96	2.96	2.47	0.00	0.00	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	87.55	6.21	4.95	2.32	1.47	0.00	0.00	0.32	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	87.36	7.97	7.63	1.73	2.77	0.35	0.35	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	73.92	3.20	4.62	3.91	1.78	0.36	0.00	1.07	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	97.51	6.60	5.92	1.59	1.59	1.02	0.68	0.91	0.57	0.00
Chondrocyte - re diff, donor2	11339-117F7	170.99	17.91	5.37	16.11	3.58	1.79	2.69	1.79	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	128.20	8.09	6.07	4.04	1.62	0.00	1.62	1.21	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	85.27	8.03	9.41	2.07	1.38	0.11	0.46	0.69	0.34	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	77.38	6.20	6.63	3.85	2.57	0.00	0.64	1.50	1.07	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	93.10	7.26	5.31	3.36	1.86	0.27	0.00	0.53	0.27	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	208.07	15.59	13.48	10.09	7.61	1.19	1.28	0.83	0.37	1.47
Corneal Epithelial Cells, donor1	11526-119I5	32.28	1.32	1.76	0.22	0.66	0.00	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	48.92	2.28	1.14	3.41	2.28	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	55.22	4.35	1.53	2.05	0.77	0.00	0.00	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	246.65	9.58	5.45	23.44	4.79	0.66	0.50	1.16	0.99	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	246.02	11.35	4.10	33.75	5.36	1.26	0.63	1.89	1.58	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	255.35	10.35	6.90	37.96	6.90	0.00	0.00	10.35	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	168.14	6.16	4.00	16.74	3.56	0.97	0.43	1.73	0.76	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	498.11	9.57	4.10	22.89	25.28	0.68	0.00	2.39	0.34	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	612.39	13.71	4.57	20.89	26.11	0.00	0.00	1.31	1.31	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	612.19	10.65	7.26	21.29	25.17	0.97	1.45	0.48	0.48	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	56.70	2.67	1.67	1.83	1.17	0.17	0.00	0.17	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	65.13	2.93	0.00	1.17	1.17	0.59	0.00	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	98.98	2.26	1.41	1.70	1.13	0.28	0.00	0.28	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	95.94	2.75	4.72	2.36	1.57	0.39	0.00	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	72.14	1.45	1.45	2.91	2.04	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	94.82	2.59	3.53	1.65	1.88	0.47	0.24	0.71	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	72.93	1.75	1.40	2.63	1.75	0.00	0.35	0.35	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	88.88	2.22	3.32	1.11	2.44	0.44	0.44	0.00	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	109.84	4.26	4.26	1.52	1.83	0.30	0.00	0.30	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	155.33	4.79	5.92	1.41	3.95	0.85	1.13	0.28	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	79.93	2.08	2.67	3.57	0.89	0.59	0.59	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	74.46	3.64	2.08	1.04	2.60	1.04	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	71.32	1.56	1.84	1.99	2.84	0.14	0.28	0.28	0.57	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	100.03	2.00	2.00	3.20	2.80	0.40	0.40	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	79.14	1.57	1.05	1.05	1.57	0.00	0.00	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	124.25	3.98	4.97	1.86	2.61	0.75	0.50	0.37	0.12	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	99.07	2.17	1.74	1.52	0.87	0.43	0.00	0.43	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	108.08	3.30	3.18	1.95	3.42	0.00	0.00	0.24	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	81.90	2.28	0.00	3.41	2.28	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	50.99	3.49	0.00	0.00	2.79	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	108.02	2.98	2.04	1.73	2.20	0.31	0.16	0.94	0.47	0.00
Eosinophils, donor1	12244-129H3	808.09	30.49	15.25	30.49	106.73	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1650.26	41.26	34.66	41.26	82.51	3.30	4.95	3.30	1.65	1.65
Eosinophils, donor3	12246-129H5	1041.51	32.10	17.83	17.83	71.34	0.00	3.57	3.57	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	37.38	1.71	3.18	0.49	0.24	0.24	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	45.76	2.08	0.00	2.08	0.00	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	130.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	160.92	11.49	9.03	3.28	4.52	0.41	0.41	0.00	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	127.77	5.80	8.32	2.85	4.27	4.93	2.41	2.08	2.08	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	59.59	2.71	3.03	0.76	1.63	0.54	0.43	0.87	0.43	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	99.81	8.13	5.82	1.70	1.58	1.82	0.85	0.49	0.36	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	92.94	6.41	5.32	2.05	3.14	0.41	0.14	0.41	0.14	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	84.06	4.11	4.43	1.90	2.53	0.63	0.84	0.53	0.53	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	124.63	14.23	10.01	9.75	3.16	1.32	2.63	0.26	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	96.67	7.64	7.97	4.32	2.33	0.33	1.33	0.33	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	76.66	4.08	1.81	2.72	1.81	0.00	0.45	0.91	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	43.20	3.79	3.03	0.00	1.52	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	100.31	4.26	3.79	3.15	2.05	1.10	0.47	1.42	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	100.33	4.85	7.27	4.24	2.42	0.61	0.61	0.30	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	113.33	5.20	4.44	1.52	1.52	0.38	0.76	0.25	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	86.11	4.24	3.94	2.88	1.21	0.00	0.45	0.61	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	93.79	9.78	5.76	1.74	1.88	0.13	0.27	0.00	0.54	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	91.46	3.02	7.77	1.73	3.02	0.86	0.00	0.00	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	106.93	4.39	8.79	1.46	0.00	1.46	0.00	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	52.12	5.07	3.00	0.92	0.23	0.00	0.23	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	122.79	7.12	7.97	2.20	2.20	0.17	0.34	0.51	0.34	0.00
Fibroblast - Dermal, donor1	11269-116G9	61.04	2.35	3.52	0.94	1.41	0.00	0.47	0.00	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	37.73	3.77	2.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	69.87	3.02	4.71	2.30	0.97	0.60	0.73	0.48	0.60	0.00
Fibroblast - Dermal, donor4	11450-119A1	68.73	3.39	4.41	1.13	1.81	0.34	0.23	0.45	0.34	0.00
Fibroblast - Dermal, donor5	11454-119A5	72.05	3.84	4.88	2.79	0.87	0.52	0.17	0.35	0.35	0.00
Fibroblast - Dermal, donor6	11458-119A9	75.20	3.25	4.55	2.27	0.81	0.00	0.00	0.49	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	76.42	5.00	3.12	2.71	1.25	0.00	0.00	0.21	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	77.03	6.29	3.93	2.36	2.88	1.05	0.52	0.00	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	68.79	5.27	5.01	0.40	0.92	0.40	0.26	0.13	0.40	0.00
Fibroblast - Gingival, donor3	11394-118C8	90.02	4.83	4.06	2.13	1.84	0.10	0.29	0.58	0.29	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	126.74	11.43	6.23	2.08	2.08	2.08	1.04	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	91.45	6.87	8.28	2.64	1.06	0.35	0.70	0.70	0.70	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	63.29	4.52	3.90	1.71	1.09	0.62	0.00	0.16	0.16	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	73.29	4.73	5.54	2.43	2.03	0.27	0.27	1.08	0.41	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	87.87	5.29	2.82	2.47	1.76	0.00	0.35	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	85.99	4.97	6.43	2.49	1.61	0.29	0.29	0.58	0.44	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	69.40	4.64	5.32	1.77	0.55	0.55	0.41	0.68	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	89.95	5.81	6.47	1.43	1.32	0.44	0.44	0.22	0.11	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	99.49	8.66	8.07	1.17	1.76	2.35	1.47	0.29	0.44	0.00
Fibroblast - Lung, donor1	11270-116H1	35.34	0.00	1.36	1.36	0.00	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	73.12	0.00	1.49	1.49	1.49	1.49	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	56.56	2.95	2.32	1.27	0.21	0.42	0.42	0.84	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	58.31	4.17	3.33	0.83	0.00	0.00	0.00	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	53.15	4.20	4.20	0.00	2.80	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	30.23	1.96	0.84	0.28	0.84	0.56	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	89.31	5.68	2.84	2.03	1.22	0.41	0.00	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	23.97	3.99	0.00	0.00	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	71.48	0.00	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	62.85	5.43	7.37	1.16	0.58	0.19	0.00	0.39	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	87.82	4.10	5.31	1.67	1.52	0.61	0.00	0.30	0.30	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	77.41	1.84	5.20	1.84	0.61	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	62.20	8.40	5.72	2.67	1.14	0.76	0.38	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	86.67	4.32	5.67	1.89	1.89	0.54	0.27	1.35	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	108.78	6.15	7.31	2.44	1.16	1.16	0.81	0.35	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	82.57	4.75	5.75	2.76	2.21	0.11	0.22	0.33	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	87.58	6.10	5.28	3.25	2.24	0.00	0.20	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	43.43	1.34	1.34	0.67	2.67	0.00	0.67	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	89.35	7.12	5.14	1.98	1.98	0.00	0.00	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	59.34	5.75	4.56	3.37	1.59	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	111.19	7.28	7.28	2.13	2.84	0.36	0.36	0.36	0.53	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	102.68	6.70	4.34	2.37	2.96	0.99	0.00	0.59	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	103.19	9.03	6.62	7.22	2.71	0.30	0.00	0.30	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	89.06	5.72	4.53	3.45	1.51	0.65	0.54	0.32	0.54	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	61.75	5.57	2.78	3.54	1.27	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	103.86	8.53	5.74	4.10	2.46	0.49	0.33	0.00	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	128.73	10.83	9.62	9.42	3.61	0.20	0.00	0.00	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	86.10	6.33	6.13	5.12	1.61	0.70	0.60	0.30	0.40	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	43.22	4.84	3.93	3.02	1.21	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	106.13	5.88	5.14	2.49	1.99	0.17	0.41	0.25	0.25	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	100.86	8.03	5.64	1.71	2.05	0.51	1.20	0.00	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	136.96	17.74	10.18	6.57	3.94	0.99	0.33	0.33	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	92.46	8.10	5.54	3.30	1.28	0.43	1.07	0.64	0.43	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	64.94	3.71	4.89	2.02	1.86	0.34	0.17	0.34	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	72.92	5.80	5.33	2.82	2.82	0.94	1.41	2.98	0.78	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	177.28	0.00	0.00	0.00	0.00	0.00	0.00	110.80	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	135.09	6.10	2.61	8.72	5.23	1.74	0.00	0.87	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	106.09	5.20	3.64	3.12	2.43	0.69	0.52	0.35	0.52	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	143.65	7.29	4.16	3.12	3.38	0.00	2.08	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	109.61	4.60	5.37	1.53	1.53	0.00	0.51	0.26	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	120.19	4.59	5.36	2.30	0.77	3.06	0.00	0.77	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	132.72	5.74	4.47	7.02	2.55	3.19	0.00	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	145.77	11.70	5.13	6.28	2.28	3.14	3.14	1.43	0.57	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	130.98	20.68	8.27	4.14	0.83	9.93	10.75	1.10	0.55	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	145.90	17.58	10.27	4.11	2.51	7.53	3.88	0.46	0.91	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	141.07	9.51	8.32	4.76	2.97	4.16	3.96	0.99	0.40	2.18
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	121.59	17.45	6.61	2.91	1.85	5.02	9.78	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	163.07	19.24	11.09	2.94	2.61	5.87	6.52	0.65	0.33	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	122.94	7.08	3.10	4.86	1.77	3.10	0.00	0.44	1.33	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	104.01	8.34	2.40	4.95	1.41	0.57	0.00	0.71	0.57	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	114.03	10.59	6.28	3.69	1.72	1.11	0.25	0.62	0.49	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	67.69	4.30	4.30	2.15	1.61	0.54	0.54	0.00	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	106.05	10.78	4.71	1.73	1.49	1.36	1.36	0.74	0.50	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	110.33	9.14	4.43	2.49	1.11	0.55	0.83	0.83	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	66.28	4.68	2.44	2.44	1.42	1.22	0.81	1.42	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	100.17	7.76	5.48	1.37	2.05	1.14	0.46	1.14	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	110.86	8.10	5.61	2.12	1.87	1.00	0.75	1.12	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	100.33	8.09	5.46	1.75	1.75	0.87	0.22	0.66	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	107.85	9.46	6.50	0.59	2.95	1.77	0.89	1.48	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	126.69	12.40	6.99	2.07	1.59	0.95	0.95	1.59	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	104.78	7.15	6.70	2.01	2.23	0.67	0.45	0.22	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	96.78	9.07	5.44	2.42	2.02	0.81	1.61	1.21	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	135.04	10.52	8.31	2.04	3.05	1.02	0.68	1.19	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	119.35	8.07	6.74	2.31	2.57	0.71	0.89	0.89	0.27	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	124.03	11.76	6.66	0.94	1.46	0.21	1.14	0.10	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	104.00	11.78	6.66	1.37	2.39	0.00	1.71	0.51	0.85	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	144.07	10.29	4.76	2.43	3.54	1.33	1.00	0.55	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	120.88	9.32	6.74	1.83	2.75	0.42	0.92	0.25	0.08	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	98.01	10.62	7.35	1.43	3.06	1.43	0.61	0.41	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	132.86	9.90	5.78	1.24	1.86	1.86	3.51	1.03	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	146.88	12.80	6.92	2.42	3.11	0.69	0.92	0.58	0.58	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	106.06	6.50	7.67	2.67	2.17	1.00	1.33	1.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	126.09	10.14	7.27	1.10	1.54	0.44	1.98	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	159.89	11.19	6.64	1.48	2.09	1.84	1.23	0.86	0.61	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	114.76	8.75	7.78	1.78	2.43	0.97	0.49	0.97	0.49	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	140.47	10.58	5.45	1.28	3.53	1.60	1.60	1.28	1.28	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	145.73	11.84	7.30	1.99	2.18	1.52	1.04	0.85	0.47	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	99.33	6.96	4.90	0.95	2.21	1.11	0.32	0.95	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	123.76	10.64	10.95	2.43	2.13	1.52	1.22	1.22	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	149.18	13.59	8.57	2.82	2.82	1.25	0.73	1.05	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	120.97	8.78	6.15	0.22	1.54	1.32	0.66	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	134.10	14.87	5.89	1.68	2.81	1.96	1.40	0.56	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	132.21	9.44	4.63	2.78	3.06	1.39	0.56	0.93	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	132.10	8.29	4.28	2.14	1.60	0.00	0.53	0.27	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	106.34	6.58	6.12	2.30	2.30	0.92	0.77	0.92	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	138.60	10.23	5.05	3.37	2.20	0.39	0.52	0.91	0.65	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	161.29	6.78	8.13	1.63	3.25	0.54	0.54	0.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	120.38	7.74	6.64	1.29	2.58	0.92	0.92	0.74	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	127.20	6.58	8.33	0.66	1.54	0.66	0.66	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	166.61	7.93	5.95	2.98	2.98	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	106.06	5.41	5.54	1.45	1.85	0.92	0.40	0.53	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	113.39	6.25	4.84	0.81	1.21	0.61	0.81	1.61	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	176.13	12.71	12.20	1.27	2.03	0.00	0.25	0.25	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	91.37	5.57	5.18	4.78	0.60	0.60	1.00	0.60	0.40	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	87.52	7.55	3.54	4.16	1.08	1.08	0.15	0.92	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	94.11	9.21	3.27	5.52	2.86	0.20	0.00	0.61	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	135.19	8.76	5.01	6.57	1.56	0.31	0.00	0.00	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	116.13	7.91	5.65	5.37	2.83	0.57	0.28	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	89.01	5.53	3.23	4.61	4.15	0.92	0.92	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	84.14	0.00	7.42	7.42	4.95	0.00	2.47	2.47	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	97.86	10.44	7.74	3.87	1.16	1.93	1.93	0.77	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	144.40	8.02	6.42	4.81	3.21	3.21	3.21	3.21	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	92.16	10.43	6.96	5.22	5.22	0.00	0.00	3.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	94.39	9.44	3.58	3.58	2.28	1.63	1.30	0.65	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	110.36	9.47	4.53	5.77	2.06	2.06	1.24	2.88	1.24	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	166.61	0.00	6.66	3.33	0.00	3.33	0.00	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	107.66	7.83	5.31	2.80	2.80	1.12	0.56	0.00	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	106.88	9.81	3.27	2.61	2.61	1.63	1.63	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	102.34	13.42	4.19	3.36	1.68	1.68	1.68	0.00	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	130.41	8.27	5.09	1.59	1.91	2.54	3.18	0.32	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	110.73	5.09	6.11	3.74	0.34	1.36	1.36	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	169.14	6.26	0.00	4.18	4.18	2.09	2.09	6.26	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	152.34	9.74	3.44	4.58	4.01	4.01	1.72	0.57	1.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	105.07	6.81	5.03	1.18	2.07	0.89	0.59	1.18	0.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	199.91	6.78	5.08	3.39	1.69	1.69	0.00	5.08	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	151.19	12.43	4.56	2.07	1.66	4.14	2.90	1.24	0.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	119.67	9.44	2.30	2.76	2.99	0.92	1.61	0.69	0.69	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	284.50	15.81	5.27	0.00	10.54	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	181.44	14.61	4.61	3.08	4.23	4.23	1.15	0.77	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	209.27	15.97	5.22	1.96	5.87	2.93	2.61	0.33	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	309.67	14.71	6.69	2.68	5.35	4.68	2.68	0.67	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	209.20	16.95	6.93	0.77	4.62	5.39	4.62	4.24	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	225.60	16.43	5.82	5.14	6.85	3.42	3.08	1.03	1.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	295.69	32.30	0.00	0.00	2.48	9.94	2.48	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	219.41	13.68	8.97	1.42	5.19	5.66	2.36	0.94	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	284.25	35.61	9.66	0.00	3.62	9.05	0.00	1.21	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	319.45	19.33	10.68	2.54	3.56	6.10	4.07	0.51	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	241.70	17.55	5.18	1.60	2.39	4.79	2.39	2.39	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	331.04	24.17	4.93	0.00	5.43	5.43	1.97	4.44	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	329.34	29.51	16.53	1.18	7.08	7.08	1.18	2.36	2.36	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	341.90	29.17	9.34	2.92	4.08	5.25	2.33	2.92	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	316.87	35.99	6.58	1.32	5.27	4.83	1.76	3.07	2.19	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	265.33	22.89	5.93	1.70	4.24	5.09	2.54	1.70	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	196.38	13.73	10.15	2.39	2.98	4.18	0.00	1.19	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	265.92	26.20	4.85	5.34	5.82	2.91	5.34	1.94	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	63.91	5.71	5.71	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	57.80	6.24	3.74	0.83	0.42	0.42	0.42	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	42.73	3.37	1.12	3.37	1.12	0.00	1.12	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	57.41	2.85	4.12	1.59	0.63	0.00	0.00	0.95	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	58.90	3.76	6.27	2.09	0.84	0.42	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	95.73	7.19	2.09	3.71	1.97	0.23	0.35	0.81	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	101.45	7.60	2.87	3.21	2.87	0.00	0.00	0.51	0.68	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	94.19	7.51	4.32	5.92	2.28	0.00	0.23	0.68	0.68	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	94.22	7.11	2.95	3.39	1.31	0.55	0.33	1.75	0.55	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	99.50	6.45	4.30	4.51	1.72	0.43	0.43	0.21	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	89.34	6.24	3.66	4.74	3.66	0.22	0.22	0.86	0.65	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	105.11	5.11	2.86	4.36	1.62	0.00	0.12	0.62	0.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	84.06	6.69	3.60	4.97	2.40	0.51	0.34	0.69	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	82.34	5.13	3.20	5.13	2.24	0.00	0.00	0.32	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	93.46	2.24	2.80	0.56	1.68	0.00	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	48.04	0.87	0.43	0.87	0.87	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	66.10	2.64	5.29	0.00	0.00	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	70.19	6.70	2.47	3.17	1.06	0.00	0.35	0.00	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	40.68	4.36	3.63	1.45	2.18	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	72.38	4.02	5.25	3.32	2.45	0.52	0.00	0.70	0.70	0.00
Hepatocyte, donor1	11523-119I2	276.02	10.90	6.05	18.16	13.32	1.21	0.00	2.42	1.21	0.00
Hepatocyte, donor2	11603-120I1	326.43	14.01	4.31	9.70	12.93	9.70	7.54	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	333.15	11.66	4.29	7.36	11.04	3.07	3.07	1.84	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	311.33	9.14	4.57	5.22	6.53	0.65	0.00	5.22	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	94.21	8.74	2.80	7.17	2.80	0.00	0.52	0.87	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	70.52	5.35	5.21	1.37	1.65	0.27	0.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	50.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00	6.68	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	22.15	1.38	0.00	1.38	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	0.00	0.00	2.50	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	17.94	2.56	0.00	2.56	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	32.00	0.00	0.00	4.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	37.36	1.62	1.62	1.62	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	18.34	0.00	0.00	3.33	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	0.00	14.52	0.00	7.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	19.85	0.00	2.65	1.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	36.59	0.00	0.00	3.33	4.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	0.00	0.00	15.71	0.00	5.24	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	33.38	1.89	1.26	3.15	1.26	0.00	0.00	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	29.39	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	26.49	1.29	1.29	1.29	0.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	27.37	0.00	0.00	0.00	1.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	30.15	0.00	0.81	1.63	1.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	22.67	2.52	0.00	0.84	0.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	39.38	1.61	0.80	2.41	0.00	0.80	0.00	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	26.78	0.92	1.85	0.92	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	33.04	0.47	1.89	3.78	0.94	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	18.14	1.81	0.00	0.91	0.91	0.00	0.91	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	31.21	2.15	0.00	1.08	0.00	0.00	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	13.98	2.54	1.27	3.81	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	28.70	1.91	1.28	0.64	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	20.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	19.99	2.14	1.43	0.71	0.00	0.00	0.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	0.00	0.00	0.00	0.00	0.00	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	29.01	1.54	0.31	1.85	0.62	0.00	0.00	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	15.80	0.00	1.76	1.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	34.57	0.00	0.00	3.14	3.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	27.12	2.78	0.70	2.78	0.70	0.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	2.21	6.64	4.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	3.24	0.00	3.24	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	28.77	0.00	0.87	1.74	0.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	29.25	6.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	3.48	0.00	3.48	3.48	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	36.27	1.07	2.13	2.13	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	18.01	0.00	0.00	1.39	1.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	22.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	14.73	1.84	0.92	2.76	0.00	0.00	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	0.00	0.00	3.03	3.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	40.18	4.23	0.00	3.17	2.11	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	62.42	3.67	3.02	3.02	1.47	0.49	0.49	0.08	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	31.62	2.34	1.76	1.17	0.59	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	92.76	2.18	3.31	1.89	1.23	0.28	0.28	0.57	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	74.81	4.77	4.65	2.61	1.36	0.57	0.11	0.23	0.68	0.00
Keratocytes, donor1	11527-119I6	51.57	4.47	3.09	2.06	0.34	0.34	0.00	0.00	0.34	0.00
Keratocytes, donor2	11607-120I5	37.50	0.00	3.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	79.04	1.98	3.75	1.98	1.19	0.59	0.40	0.40	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	96.71	8.79	2.20	6.59	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	61.49	4.31	3.24	1.08	0.00	0.00	0.00	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	98.03	10.03	7.27	2.19	1.15	0.12	0.35	0.00	0.35	0.00
Lens Epithelial Cells, donor3	11690-122I7	84.26	7.77	7.37	2.72	1.61	0.00	0.00	0.20	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	94.39	3.91	3.79	2.13	3.32	0.59	0.24	0.71	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	75.91	1.40	2.79	1.40	3.35	0.00	0.28	0.28	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	132.23	5.04	2.99	3.31	3.78	1.26	0.16	0.63	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	73.13	2.69	0.54	1.61	2.69	0.00	0.00	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	68.71	2.21	1.26	2.84	0.63	0.00	0.00	0.00	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	70.40	2.70	1.73	1.40	1.40	0.54	0.11	0.54	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	87.00	2.87	2.05	2.46	1.23	0.41	0.41	0.82	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	48.29	1.01	1.52	1.52	1.01	0.76	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	72.91	3.38	2.82	1.41	1.41	0.42	0.14	0.99	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	83.85	2.77	1.58	1.98	2.37	0.79	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	88.02	2.71	1.16	2.71	1.16	0.19	0.19	0.19	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	49.99	1.30	2.04	1.11	0.56	0.56	0.00	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	89.20	3.14	2.09	1.39	1.39	0.70	0.00	0.70	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	78.71	2.39	2.62	1.43	1.19	0.48	0.24	0.48	0.72	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	66.06	1.79	1.51	1.37	1.51	0.41	0.14	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	98.24	2.16	3.08	2.16	1.85	0.92	0.31	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	50.19	0.31	0.62	0.94	1.87	0.00	0.00	0.62	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	69.35	3.11	2.01	0.91	1.65	0.73	0.18	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	87.87	3.29	0.33	2.63	0.66	0.33	0.99	1.32	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	45.10	1.17	1.46	1.76	0.88	0.88	0.00	0.88	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	55.76	2.24	1.24	1.24	1.00	1.99	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	85.84	1.94	1.45	1.45	2.91	0.97	0.00	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	77.83	2.42	3.23	2.15	2.42	0.54	0.54	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	79.78	2.88	1.21	2.12	2.27	0.45	0.45	0.61	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	78.28	3.63	1.04	3.63	2.07	0.00	0.00	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	88.78	1.88	2.51	3.77	1.88	0.42	0.00	0.42	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	76.54	3.16	2.56	1.80	2.41	0.30	0.45	0.90	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	74.29	2.06	2.06	0.00	1.38	0.00	0.69	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	67.36	2.07	2.45	3.57	2.26	0.19	0.56	0.75	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	62.45	2.33	1.48	1.59	1.38	0.42	0.11	0.21	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	81.41	1.94	1.94	2.91	1.45	1.45	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	74.76	3.64	0.66	3.31	2.32	0.66	0.00	1.98	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	63.31	1.86	1.49	1.12	0.99	0.87	0.12	0.50	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	108.84	4.81	1.11	2.59	3.33	0.74	0.37	0.74	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	74.12	1.24	3.46	2.72	1.48	0.00	0.25	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	60.50	2.06	0.96	1.79	1.51	1.24	0.14	0.27	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	87.81	3.86	1.29	2.25	5.15	0.32	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	89.17	3.04	1.22	5.17	0.91	0.91	0.30	0.61	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	102.74	3.36	2.80	3.08	3.22	0.14	0.28	0.56	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	104.54	3.91	2.84	2.13	3.20	0.36	0.36	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	55.75	0.48	1.45	1.94	0.00	0.48	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	51.82	2.18	0.93	1.40	1.09	0.31	0.00	0.16	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	85.95	2.86	1.79	1.79	1.43	0.36	0.36	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	70.89	2.29	2.29	4.57	1.96	0.00	0.00	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	44.02	0.47	0.94	0.71	0.47	1.18	0.24	0.47	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	84.52	3.34	2.48	1.73	3.34	0.37	0.25	0.25	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	38.42	1.79	0.77	2.31	0.77	0.26	0.00	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	56.69	0.90	1.49	2.09	1.49	0.30	0.30	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	54.38	4.53	0.00	2.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	49.86	2.30	0.77	3.84	2.30	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	30.43	5.20	2.23	2.97	0.00	0.00	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	29.62	1.69	2.54	1.69	0.00	0.42	0.00	1.27	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	29.54	2.11	1.41	2.11	2.11	1.41	0.70	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	27.09	3.74	0.93	3.74	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	30.40	1.03	1.55	5.67	1.55	1.03	0.00	1.55	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	23.79	3.57	2.38	2.38	1.19	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	34.83	2.71	1.13	4.75	1.36	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	45.66	4.07	2.04	4.65	0.58	0.29	0.00	0.58	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	47.27	3.60	0.90	6.30	0.45	0.00	0.00	0.90	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	38.07	3.52	1.35	3.66	1.63	0.14	0.27	0.27	0.27	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	32.87	3.59	0.51	2.57	1.03	0.00	0.51	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	44.46	4.23	2.47	4.94	1.76	0.00	0.35	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	36.65	2.67	2.00	3.33	0.00	0.00	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	47.37	1.53	1.02	5.09	1.53	0.00	0.00	3.06	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	52.83	3.74	1.60	2.13	0.53	0.53	0.27	1.07	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	47.80	4.35	0.94	4.72	1.51	0.76	0.19	1.32	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	47.86	1.23	1.84	3.68	1.23	0.61	0.00	0.61	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	44.85	5.71	0.82	4.08	0.00	0.00	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	48.73	2.71	1.46	4.58	1.04	0.21	0.00	0.83	0.62	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	54.65	4.20	0.84	4.76	1.68	0.84	0.28	2.80	1.68	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	42.24	2.06	1.03	3.09	1.03	0.00	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	38.61	4.06	1.16	4.64	1.16	2.32	0.29	1.16	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	49.62	2.09	1.79	6.28	2.09	0.30	0.00	2.09	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	47.58	6.09	2.77	5.53	0.00	0.00	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	33.93	3.53	0.00	4.95	0.00	0.35	0.00	0.35	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	48.31	2.95	1.11	6.64	1.11	0.74	0.00	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	29.93	3.45	0.00	4.61	0.00	1.15	0.00	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	40.29	3.07	1.54	6.91	1.15	0.38	0.00	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	39.63	3.40	1.70	5.10	1.13	0.57	0.00	1.70	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	45.13	1.64	2.46	4.92	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	31.63	3.16	2.71	4.52	0.45	0.45	0.45	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	39.50	3.59	2.15	4.31	2.15	0.72	0.00	2.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	35.10	1.49	0.75	5.23	0.00	0.00	0.00	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	28.61	5.20	1.49	5.95	1.11	0.74	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	49.97	4.31	1.72	3.88	1.29	0.43	0.43	0.00	1.29	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	50.52	3.43	1.71	6.85	0.00	0.00	0.00	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	40.98	3.33	0.67	4.00	1.00	0.00	0.33	0.33	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	35.60	3.62	1.21	4.22	2.41	0.00	0.60	1.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	30.57	1.42	0.71	5.69	0.71	0.71	0.00	1.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	39.53	2.06	1.72	4.47	1.72	0.00	0.34	0.34	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	32.20	2.68	0.54	3.22	1.07	0.54	0.00	2.15	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	25.59	1.35	1.35	3.37	0.67	0.00	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	32.97	2.96	1.11	5.93	1.85	0.37	0.00	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	38.38	1.16	2.33	5.81	0.00	0.00	0.00	1.16	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	27.50	2.12	0.00	4.23	3.17	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	31.21	3.20	0.40	6.00	0.40	0.00	0.40	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	30.53	3.63	0.00	2.18	2.18	1.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	39.09	0.00	3.83	6.13	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	39.96	4.44	0.49	6.41	0.00	0.99	0.00	0.00	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	30.11	1.88	2.82	1.88	0.00	0.00	0.00	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	37.21	3.02	2.01	4.02	1.01	0.00	0.00	1.01	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	30.19	2.25	2.70	2.70	1.80	0.90	0.45	0.90	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	5.16	0.00	5.16	0.00	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	29.39	2.67	0.89	0.89	0.45	0.00	0.00	1.34	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	39.49	4.30	0.78	2.74	1.17	0.00	0.00	0.39	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	40.90	2.64	0.00	2.64	1.32	0.00	0.00	1.32	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	34.25	3.63	1.04	2.59	2.08	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	33.26	5.25	0.88	2.63	0.00	0.88	0.00	1.31	1.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	35.78	3.91	1.68	3.35	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	41.51	6.62	1.32	2.65	0.00	0.00	0.00	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	33.56	1.93	2.31	1.93	0.39	0.00	0.39	1.16	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	35.44	1.52	1.52	3.04	1.52	0.51	0.00	1.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	39.89	1.92	0.96	2.88	0.96	0.00	0.00	0.00	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	30.61	4.37	0.40	5.57	0.40	0.40	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	45.57	1.22	0.61	4.25	1.22	0.61	0.61	0.61	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	28.36	1.38	0.69	2.77	0.00	0.69	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	33.82	4.18	1.90	3.80	0.76	0.00	0.00	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	33.57	4.65	1.03	5.68	1.55	0.52	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	36.88	3.02	0.60	3.02	1.21	0.00	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	33.59	2.54	1.90	4.12	0.95	0.32	0.00	0.95	1.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	33.58	3.73	1.07	5.86	0.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	31.03	3.45	1.15	4.02	0.57	0.57	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	28.80	3.60	1.54	2.06	1.03	0.00	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	33.95	2.83	0.71	2.83	0.71	0.00	0.00	2.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	34.62	4.54	0.57	3.40	0.57	0.00	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	37.86	2.08	0.83	6.66	1.25	0.00	0.42	1.66	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	31.32	1.57	1.57	5.48	1.57	2.35	0.00	0.78	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	29.65	3.76	0.42	3.34	0.42	0.42	0.00	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	33.45	1.86	1.39	5.11	0.93	0.46	0.00	0.00	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	29.44	4.01	0.67	6.69	1.34	0.00	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	38.49	4.81	0.53	3.74	1.60	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	31.52	2.02	0.81	4.85	0.00	0.40	0.81	1.62	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	33.96	2.75	0.92	3.67	2.75	0.92	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	27.56	1.78	3.56	3.56	0.00	0.89	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	43.88	2.28	1.14	4.56	1.14	0.00	0.00	0.00	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	36.04	2.30	1.53	4.60	1.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	22.43	4.38	0.55	1.09	1.09	0.00	0.00	0.55	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	35.64	1.78	1.34	2.23	0.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	29.63	1.82	1.30	3.64	0.26	0.00	0.00	0.00	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	26.52	1.99	1.33	2.65	0.66	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	0.00	0.00	4.16	0.00	0.00	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	196.01	7.29	10.03	4.33	2.96	1.14	0.00	0.91	0.91	0.00
Macrophage - monocyte derived, donor2	11313-117C8	158.92	8.44	8.81	14.50	2.20	0.00	0.37	0.73	0.55	0.00
Macrophage - monocyte derived, donor3	11389-118C3	176.57	6.95	8.52	8.52	4.59	1.70	0.26	1.44	0.52	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	97.18	8.50	5.31	6.90	7.43	0.00	0.00	1.06	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	145.30	9.98	8.24	4.12	5.86	0.79	0.79	0.79	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	99.10	3.47	2.92	3.06	5.28	0.42	0.28	0.56	0.42	0.00
Mammary Epithelial Cell, donor1	11273-116H4	86.29	5.48	4.38	4.68	1.49	0.50	0.10	0.00	0.30	0.20
Mammary Epithelial Cell, donor2	11350-117G9	76.44	2.90	2.03	4.92	2.61	0.58	0.00	0.00	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	42.65	2.00	1.25	1.50	1.25	0.00	0.25	0.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	305.75	21.69	10.17	35.25	13.56	1.36	0.00	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	368.44	14.60	8.98	11.57	13.95	2.38	3.78	0.43	0.32	0.22
Mast cell, donor2	11565-120D8	696.87	32.69	16.64	13.37	40.12	5.35	4.16	2.67	0.30	2.38
Mast cell, donor3	11566-120D9	672.67	30.62	16.88	22.29	38.27	5.40	4.95	1.13	0.90	15.76
Mast cell, donor4	11567-120E1	667.85	28.54	14.54	22.69	42.02	3.55	4.61	0.71	0.71	9.04
Mast cell, expanded and stimulated, donor5	11940-126A5	354.64	23.29	12.75	45.13	14.08	2.22	2.77	2.66	0.44	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	321.61	13.42	8.76	65.37	8.76	5.84	4.09	1.75	2.33	0.00
Mast cell, expanded, donor5	11939-126A4	360.69	18.58	11.24	11.82	16.29	5.74	3.33	2.52	1.15	1.26
Mast cell, expanded, donor8	11941-126A6	519.84	18.58	8.70	15.40	24.60	7.87	7.03	2.68	1.84	0.67
Melanocyte - dark, donor1	11502-119F8	167.85	5.07	4.58	2.59	3.78	0.30	0.00	0.50	0.10	0.10
Melanocyte - dark, donor2	11582-120F7	76.83	4.50	6.23	3.46	1.73	0.69	0.00	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	115.76	8.84	10.00	3.48	3.48	0.22	0.29	0.36	0.22	0.00
Melanocyte - light, donor1	11274-116H5	47.72	4.00	2.59	1.65	0.94	0.00	0.00	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	38.90	1.36	3.41	1.36	1.36	0.00	0.00	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	34.69	1.73	2.60	3.47	0.00	0.87	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	116.00	7.60	6.14	1.67	1.98	0.73	0.42	1.25	0.21	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	135.82	9.41	8.34	5.11	1.61	0.81	0.00	1.88	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	81.70	3.75	4.55	1.61	3.21	0.80	1.34	0.80	0.27	0.00
Meningeal Cells, donor1	11493-119E8	73.20	5.09	5.09	2.61	1.98	0.12	0.00	0.12	0.00	0.00
Meningeal Cells, donor2	11573-120E7	101.67	8.36	5.72	0.88	2.20	0.00	0.00	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	80.12	4.56	6.76	4.73	1.87	0.24	0.00	0.00	0.41	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	68.44	5.99	4.56	1.71	1.14	0.29	0.00	0.86	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	146.82	8.65	4.13	6.94	3.42	0.40	0.91	0.81	0.60	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	14.46	2.63	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	26.16	0.00	1.31	0.00	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	64.58	2.87	2.87	5.02	1.44	0.00	0.00	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	116.90	7.41	8.47	2.54	3.18	0.42	2.75	0.42	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	113.60	8.04	6.53	4.52	3.02	0.50	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	36.26	2.86	2.42	2.42	0.88	0.00	0.22	0.22	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	32.88	2.92	1.46	2.92	0.73	0.00	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	34.78	2.05	2.05	1.23	0.20	0.00	0.00	0.00	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	76.87	7.76	6.51	0.83	2.08	0.97	0.00	0.14	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	48.70	5.20	1.49	2.23	0.37	0.37	0.74	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	140.39	9.34	5.26	2.63	3.29	0.79	0.53	0.79	0.39	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	54.90	4.15	2.97	0.89	1.19	0.00	0.00	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	67.73	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	64.68	2.56	3.84	1.28	0.64	0.64	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	76.56	7.09	3.90	1.42	2.48	0.00	0.35	0.00	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	123.53	5.94	4.07	3.13	2.50	0.63	0.63	0.94	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	68.22	2.90	3.63	3.63	0.73	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	349.50	16.18	10.87	7.16	9.28	2.12	2.12	2.65	1.33	0.00
Mesothelial Cells, donor2	12156-128G5	210.70	8.51	9.51	2.50	3.50	1.00	0.50	1.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	298.67	11.56	8.82	4.19	9.61	1.81	1.08	2.82	1.52	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	168.79	8.10	5.40	6.75	1.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	219.43	4.93	4.43	14.28	6.90	0.74	0.00	0.99	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	181.68	5.30	6.18	15.02	5.89	0.29	0.00	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	103.71	0.00	3.46	3.46	10.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	174.81	8.06	5.58	8.37	2.79	0.62	0.93	1.55	1.24	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	142.92	7.26	5.19	9.13	2.90	0.21	0.00	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	85.69	2.32	0.00	2.32	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	236.75	7.51	4.25	11.26	4.25	1.00	0.00	2.50	0.75	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	192.71	6.52	4.19	12.10	5.12	0.47	0.47	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	177.20	6.30	4.88	10.77	3.25	0.81	0.41	1.42	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	154.82	4.75	3.96	12.27	3.56	0.79	0.00	1.98	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	111.17	0.00	0.00	17.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	134.51	4.42	6.19	7.96	1.77	2.65	0.88	0.88	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	153.11	6.08	4.56	21.66	5.70	0.38	0.76	1.52	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	80.27	0.00	0.00	1.32	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	144.74	5.09	4.88	9.55	3.40	0.42	0.21	2.76	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	121.55	1.84	6.45	10.13	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	139.79	4.17	5.07	6.26	3.87	0.30	0.00	1.49	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	117.37	3.35	0.00	8.38	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	154.56	6.52	5.77	6.02	2.76	1.76	0.50	1.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	129.05	6.18	4.52	11.17	4.28	0.24	0.24	1.19	0.71	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	74.64	2.76	3.32	6.63	0.55	0.00	0.00	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	118.12	4.14	3.68	9.21	2.30	0.92	0.23	1.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	140.30	5.05	4.84	10.52	3.58	0.42	0.21	1.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	102.53	3.26	3.06	6.73	1.83	0.61	0.20	0.20	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	135.59	6.01	5.79	6.65	3.65	0.21	0.21	0.64	1.29	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	141.38	5.33	3.78	9.56	5.11	0.22	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	114.55	3.72	4.38	4.82	1.97	0.88	0.44	0.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	125.73	3.04	3.55	4.06	3.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	96.11	3.31	1.66	11.60	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	117.14	3.81	2.99	3.81	2.72	0.82	0.27	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	133.51	5.59	4.41	8.53	4.12	0.29	0.29	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	76.32	0.00	1.09	2.18	1.09	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	121.10	2.88	3.36	6.73	2.40	0.48	0.48	1.44	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	118.07	4.00	2.80	12.41	1.60	0.00	0.00	1.20	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	61.70	4.11	2.74	6.86	2.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	92.61	5.01	4.00	3.00	3.50	0.50	0.00	2.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	26.95	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	73.39	4.08	0.00	4.08	4.08	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	90.65	3.94	2.63	7.01	1.75	0.00	0.44	1.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	76.15	2.21	2.21	5.52	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	40.34	0.64	1.28	4.48	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	76.85	2.73	2.73	5.70	2.23	0.99	0.00	1.24	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	84.90	2.78	1.39	2.78	0.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	24.31	0.00	2.21	11.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	80.68	4.10	5.47	3.08	1.71	0.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	87.96	2.19	3.94	3.50	0.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	47.58	0.36	1.78	3.91	0.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	70.14	2.52	3.93	3.93	1.40	0.56	0.56	0.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	86.45	1.25	1.66	3.74	2.08	0.00	0.00	0.83	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	33.80	0.58	1.17	2.33	1.17	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	66.67	3.32	4.52	3.02	3.02	0.00	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	93.50	5.01	2.50	5.84	4.59	0.83	0.42	0.42	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	0.00	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	57.26	1.85	1.85	2.77	2.77	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	116.67	5.12	3.98	8.54	3.98	0.57	0.00	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	70.47	2.35	1.11	3.73	1.38	0.00	0.14	0.28	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	91.74	5.44	1.30	3.63	2.07	0.00	0.26	1.55	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	118.83	3.86	3.86	6.01	3.43	0.00	0.00	0.00	1.29	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	50.82	1.91	1.27	2.54	0.64	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	69.92	3.47	3.20	2.94	3.47	0.00	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	170.92	5.99	4.19	7.48	6.59	0.60	1.50	0.90	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	89.56	1.55	2.54	3.11	2.54	0.00	0.00	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	95.87	4.14	4.78	2.87	3.82	0.64	0.32	1.91	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	138.65	9.51	4.20	6.19	7.30	0.22	0.44	0.66	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	70.15	3.03	2.65	4.55	1.52	0.00	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	100.01	2.56	4.26	3.13	1.99	0.28	0.57	1.14	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	144.78	5.41	4.67	5.65	5.65	0.49	0.49	0.49	0.74	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	83.41	1.96	1.30	6.52	1.96	0.00	0.00	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	119.08	5.88	4.70	5.29	6.17	0.00	0.00	0.59	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	167.23	5.77	8.07	6.63	5.77	0.86	0.58	0.29	0.86	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	147.96	6.18	4.95	4.95	6.18	0.00	0.41	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	136.98	4.76	5.36	3.28	5.36	0.30	0.00	0.30	0.89	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	305.12	22.60	0.00	11.30	0.00	0.00	0.00	3.77	7.53	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	228.13	8.91	5.35	3.56	8.91	0.00	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	293.09	9.53	5.59	3.29	7.89	1.31	0.66	2.63	2.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	270.35	14.73	12.62	8.42	5.26	2.10	1.05	4.21	3.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	351.09	14.83	12.85	8.30	8.50	0.59	0.40	2.77	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	319.44	15.83	8.38	13.04	7.45	2.79	0.00	0.00	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	244.85	9.01	7.89	9.76	10.89	0.00	0.00	3.00	1.50	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	224.53	7.72	5.59	8.79	7.19	0.27	0.27	1.07	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	182.09	6.79	4.30	3.62	3.96	0.90	0.34	1.13	0.90	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	242.38	11.79	5.16	5.16	5.16	2.21	2.21	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	251.73	5.13	6.60	2.56	6.23	1.47	0.73	2.56	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	191.34	3.11	6.22	6.22	4.67	4.67	0.00	1.56	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	240.50	8.55	4.81	7.48	9.62	1.60	1.07	0.53	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	170.01	3.86	0.00	0.00	3.86	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	222.19	8.08	3.03	4.04	6.06	3.03	0.00	4.04	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	191.42	6.32	5.90	11.38	5.06	0.42	0.00	1.69	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	318.69	10.90	6.81	8.17	9.53	5.45	4.09	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	261.95	12.72	10.17	10.17	5.09	2.54	1.91	2.54	1.91	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	308.55	11.34	3.24	8.91	9.72	0.81	0.00	3.24	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	238.65	6.04	7.55	9.06	15.10	0.00	1.51	3.02	1.51	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	405.42	11.42	5.71	11.42	11.42	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	264.26	3.26	6.52	22.84	19.57	0.00	0.00	0.00	0.00	16.31
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	109.31	14.26	14.26	9.50	4.75	4.75	0.00	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	539.61	12.55	0.00	25.10	50.20	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	88.54	6.68	6.46	1.94	1.72	0.65	1.29	0.65	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	95.12	5.23	3.66	4.18	2.09	0.52	1.57	0.52	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	184.23	2.67	9.34	5.34	4.67	0.00	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	135.23	3.34	9.18	3.76	3.34	0.42	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	76.63	7.04	5.51	2.66	0.76	0.00	0.00	0.76	0.57	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	153.20	9.58	11.17	3.19	7.98	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	167.27	4.76	8.16	2.72	6.12	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	53.29	9.19	5.51	1.84	0.00	0.00	0.00	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	223.08	8.79	10.04	5.86	7.12	0.42	0.00	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	166.19	5.81	10.23	3.72	3.95	0.00	0.00	0.46	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	217.80	7.84	10.27	4.32	3.78	0.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	96.29	5.89	6.52	0.84	1.89	0.00	0.21	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	122.48	22.27	0.00	0.00	11.13	0.00	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	148.41	8.93	8.44	3.97	3.97	0.99	0.99	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	95.28	2.98	7.31	1.62	3.25	0.54	0.27	0.81	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	192.45	6.57	7.93	2.72	5.44	0.45	0.00	0.23	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	178.82	6.37	7.35	1.80	3.59	0.49	0.65	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	91.31	4.19	4.92	2.00	2.92	0.91	0.36	0.36	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	219.07	7.43	11.14	3.18	4.24	0.53	0.00	0.53	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	180.69	7.80	10.81	4.20	4.80	0.60	0.00	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	67.93	4.92	3.61	0.98	1.31	0.66	0.00	0.33	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	183.44	7.32	7.81	1.63	3.90	0.49	0.00	0.33	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	109.36	4.23	5.47	1.41	2.82	0.35	0.00	0.18	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	220.11	4.92	10.55	1.41	10.55	0.70	0.70	0.00	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	165.04	5.52	7.36	1.84	4.14	1.38	0.00	0.46	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	249.04	8.03	10.93	2.89	4.82	0.32	0.32	0.96	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	75.88	4.14	2.76	3.45	1.72	1.03	1.72	3.10	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	91.02	15.17	2.53	2.53	0.00	0.00	0.00	10.11	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	118.97	4.01	6.68	1.34	2.90	0.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	207.89	8.04	8.89	2.96	3.39	0.42	0.42	0.00	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	113.69	5.22	6.17	0.71	2.37	0.24	0.47	0.24	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	291.03	11.59	19.32	1.72	2.58	1.72	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	0.00	0.00	0.00	0.00	0.00	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	267.58	9.00	13.33	1.33	3.67	1.00	0.00	0.67	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	136.16	7.66	6.76	1.80	3.16	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	209.91	10.71	13.89	5.56	4.76	0.79	0.40	0.40	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	209.87	12.07	11.14	0.93	7.43	0.93	0.93	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	150.21	6.81	5.30	4.54	2.27	0.76	0.38	1.51	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	229.75	9.45	11.73	6.52	3.91	0.98	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	254.93	6.97	12.20	1.74	3.05	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	124.83	8.14	6.78	1.81	3.17	0.90	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	248.70	8.82	11.46	2.65	6.17	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	194.80	7.31	6.65	1.33	7.31	0.00	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	295.15	7.44	12.90	3.47	4.96	1.49	0.50	0.50	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	277.55	8.42	10.72	3.83	8.04	0.38	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	139.43	14.21	9.07	3.02	4.23	0.60	0.30	1.21	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	109.41	7.07	5.97	2.87	1.77	0.00	0.44	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	268.35	10.16	14.91	1.36	6.10	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	122.63	15.33	10.22	0.00	0.00	0.00	0.00	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	247.53	9.75	12.80	3.05	1.22	1.83	0.00	0.00	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	229.76	12.27	11.65	3.78	5.67	0.63	0.00	0.00	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	187.04	9.08	11.20	2.12	3.03	0.61	0.00	0.91	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	209.65	7.91	11.87	1.58	3.96	2.37	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	80.49	5.67	4.53	5.67	0.00	1.13	0.00	1.13	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	116.33	10.12	5.06	5.06	0.00	0.00	5.06	30.35	0.00	0.00
Myoblast, donor1	11241-116D8	68.70	4.97	4.72	1.74	1.61	0.25	0.62	0.62	0.50	0.00
Myoblast, donor2	11322-117D8	73.84	3.64	4.41	2.69	1.34	0.38	0.00	1.15	0.38	0.00
Myoblast, donor3	11398-118D3	75.51	5.89	6.22	2.19	1.01	0.17	0.17	0.84	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	127.98	7.15	1.31	1.90	2.63	0.44	0.15	0.44	0.15	0.58
Natural Killer Cells, donor1	11230-116C6	663.93	15.07	7.69	31.06	71.65	1.85	2.15	0.92	2.46	13.22
Natural Killer Cells, donor2	11311-117C6	736.10	17.49	3.62	39.81	75.99	4.82	2.71	7.54	3.32	7.84
Natural Killer Cells, donor3	11387-118C1	742.47	16.93	4.79	30.92	69.76	3.31	2.21	5.15	2.94	13.25
Neural stem cells, donor1	11275-116H6	254.42	24.32	17.78	12.34	4.36	1.81	1.81	0.73	0.36	0.00
Neural stem cells, donor2	11352-117H2	271.52	44.29	17.33	3.85	15.41	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	218.48	20.48	15.93	3.41	9.10	2.28	1.14	1.14	0.00	0.00
Neurons, donor2	11574-120E8	232.27	23.56	14.53	8.37	7.05	0.44	0.88	1.98	0.00	0.00
Neurons, donor3	11655-122E8	334.62	25.49	21.38	8.22	11.51	4.11	2.47	5.76	2.47	0.00
Neutrophils, donor1	11233-116C9	1058.85	31.55	20.42	17.63	44.54	8.35	8.35	4.64	5.57	1.86
Neutrophils, donor2	11314-117C9	666.74	20.29	8.70	14.49	37.69	5.80	17.39	20.29	8.70	0.00
Neutrophils, donor3	11390-118C4	1134.95	39.70	34.21	15.27	69.64	5.50	14.05	4.28	3.67	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	84.06	6.41	7.24	1.42	1.07	0.00	0.12	0.47	0.24	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	63.49	5.54	6.84	0.65	0.98	0.00	0.33	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	90.65	5.41	4.01	1.60	1.20	1.00	0.20	0.40	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	117.14	5.09	6.47	2.89	2.20	1.10	0.14	1.10	0.55	0.00
Olfactory epithelial cells, donor2	11934-125I8	125.35	6.08	6.08	2.61	2.61	1.30	0.72	1.30	1.16	0.00
Olfactory epithelial cells, donor3	11935-125I9	121.68	6.81	5.11	2.61	2.50	0.79	0.57	0.57	0.79	0.00
Olfactory epithelial cells, donor4	11936-126A1	146.58	7.21	9.93	1.46	2.24	0.29	0.10	0.68	0.19	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	109.53	10.23	4.21	4.21	3.61	0.60	0.60	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	64.45	2.98	3.40	1.06	1.28	0.21	0.43	0.21	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	68.59	5.72	4.57	3.43	0.00	1.14	2.29	1.14	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	96.83	3.10	5.59	0.62	1.86	1.86	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	34.98	2.15	2.15	1.95	0.20	0.00	0.00	0.20	0.00	0.00
Osteoblast, donor2	11354-117H4	91.30	6.32	9.13	3.51	2.11	0.70	0.00	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	80.87	5.69	5.15	1.60	2.67	0.71	0.36	0.53	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	79.35	4.97	3.87	3.45	2.27	0.84	1.18	0.59	0.25	0.00
Pericytes, donor1	11491-119E6	38.16	4.23	3.89	0.45	0.56	0.22	0.33	0.11	0.00	0.00
Pericytes, donor2	11571-120E5	61.57	7.24	4.98	1.13	0.91	0.23	0.68	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	67.55	5.90	4.88	0.61	0.61	0.20	0.20	0.41	0.00	0.00
Perineurial Cells, donor1	11499-119F5	87.93	6.67	6.22	0.68	0.79	0.34	0.00	0.34	0.34	0.00
Perineurial Cells, donor2	11579-120F4	93.58	4.32	5.15	2.39	1.10	0.28	0.18	0.18	0.09	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	797.17	22.63	7.01	22.31	58.33	1.27	1.27	0.96	1.59	5.42
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	567.59	17.87	5.39	15.92	47.99	4.41	3.18	6.61	2.20	8.33
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	576.81	12.42	4.01	21.48	50.60	2.72	1.29	3.11	0.39	1.68
Placental Epithelial Cells, donor1	11278-116H9	57.16	3.11	1.20	3.11	1.20	0.24	0.72	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	89.82	9.98	2.22	3.33	0.00	2.22	1.11	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	58.70	3.93	2.94	2.36	1.18	0.20	0.39	0.00	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	155.38	8.54	7.59	3.48	4.75	1.27	1.27	1.90	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	120.99	7.88	4.31	4.13	4.50	1.31	2.06	0.38	0.56	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	78.84	6.53	3.65	1.96	2.22	0.13	0.00	0.13	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	116.18	6.30	6.30	2.25	3.83	0.45	0.23	2.03	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	140.23	9.38	9.16	4.69	3.62	0.96	1.81	0.75	0.75	0.00
Preadipocyte - omental, donor2	11329-117E6	154.51	8.29	11.78	5.24	5.24	1.31	0.87	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	141.53	8.31	7.45	2.44	2.15	1.15	0.57	0.29	1.58	0.00
Preadipocyte - perirenal, donor1	11469-119C2	123.03	2.95	1.97	2.95	0.98	0.00	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	44.22	3.69	2.15	1.84	0.31	0.00	0.00	0.61	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	76.67	4.07	5.84	3.54	1.06	0.18	0.53	1.24	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	118.18	5.45	4.77	4.60	2.04	0.85	0.85	0.68	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	67.07	5.50	6.71	1.86	1.68	0.19	0.37	0.28	0.09	0.09
Preadipocyte - visceral, donor2	11357-117H7	92.50	6.44	9.66	1.38	1.38	2.76	0.92	0.00	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	56.01	3.66	4.70	1.67	1.04	0.31	0.21	0.10	0.31	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	68.49	3.92	1.36	4.98	1.36	2.11	4.22	0.60	0.45	0.00
Prostate Epithelial Cells, donor2	11331-117E8	84.23	5.28	5.01	3.11	3.39	1.08	0.81	1.35	0.14	0.00
Prostate Epithelial Cells, donor3	11404-118D9	72.99	4.90	2.51	1.10	1.16	0.80	0.98	0.12	0.37	0.00
Prostate Stromal Cells, donor1	11254-116F3	70.85	5.24	5.01	2.73	2.05	0.11	0.34	0.80	0.23	0.00
Prostate Stromal Cells, donor2	11332-117E9	70.29	4.48	3.41	1.61	0.90	0.54	0.54	0.90	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	87.59	5.01	4.90	1.88	2.09	1.25	1.46	0.73	0.31	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	54.02	2.92	2.92	0.73	0.00	0.36	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	91.14	7.07	6.38	1.18	1.11	0.28	0.28	0.35	0.28	0.00
Renal Epithelial Cells, donor1	11517-119H5	29.42	0.51	2.03	0.51	1.01	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	56.19	4.27	5.69	0.71	0.71	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	124.60	8.15	8.58	1.91	2.96	0.42	0.32	0.42	0.42	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	68.09	4.77	2.72	1.36	0.68	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	70.21	3.23	2.29	0.81	1.75	0.13	0.27	0.27	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	78.37	4.00	4.88	2.00	2.44	0.44	0.00	0.67	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	33.27	0.00	2.66	0.00	0.67	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	53.70	5.06	4.18	1.76	2.20	0.00	0.22	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	68.97	3.76	2.51	1.25	0.63	0.00	0.00	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	32.73	3.33	2.50	1.11	0.28	0.28	0.00	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	67.91	5.10	4.03	1.07	0.27	0.00	0.00	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	54.82	2.53	2.11	0.84	0.84	0.00	0.00	0.84	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	58.43	4.05	2.89	0.39	0.77	0.58	0.00	0.00	0.58	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	81.41	4.93	4.93	2.33	1.56	0.26	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	69.07	6.54	6.25	2.84	0.85	0.28	0.28	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	30.87	1.03	2.06	0.00	1.03	0.00	0.00	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	97.85	6.77	5.02	1.51	2.26	0.00	1.00	0.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	331.68	17.51	11.36	7.22	6.28	2.54	5.48	0.53	0.53	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	35.74	5.36	1.79	1.79	3.57	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	23.12	4.40	1.10	3.30	3.85	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	20.30	1.16	0.00	0.58	0.58	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	26.27	1.69	1.30	2.34	0.91	0.39	0.13	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	32.47	1.59	1.89	1.09	0.99	0.20	0.20	0.60	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	40.71	3.01	1.90	3.01	0.78	0.45	0.11	0.22	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	39.20	2.85	0.99	2.48	1.12	0.25	0.25	0.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	34.61	1.75	1.28	1.98	0.70	0.35	0.12	0.23	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	37.21	1.39	0.69	1.62	0.92	0.23	0.00	0.46	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	21.77	2.46	1.23	2.33	1.10	0.00	0.00	0.14	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	36.15	1.82	1.21	2.12	0.91	0.00	0.30	0.45	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	40.86	3.76	2.15	3.05	1.97	0.18	0.00	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	26.54	3.01	0.57	0.86	2.15	0.57	0.43	0.43	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	29.51	2.68	0.97	1.50	0.64	0.32	0.00	0.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	37.84	2.21	1.55	1.55	1.11	0.22	0.00	0.66	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	22.94	3.25	0.57	1.15	1.34	0.00	0.00	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	30.84	1.86	1.02	1.21	0.75	0.09	0.09	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	40.59	3.38	1.69	2.07	1.50	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	33.57	2.92	1.33	1.86	0.80	0.13	0.00	0.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	29.01	1.17	1.36	1.85	1.27	0.00	0.29	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	37.43	2.86	1.53	2.29	1.72	0.19	0.00	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	27.55	2.46	0.96	2.56	1.17	0.21	0.00	0.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	29.99	2.80	1.12	2.80	0.56	0.00	0.28	0.56	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	32.47	2.22	1.20	2.22	1.71	0.17	0.00	0.00	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	28.08	3.10	1.09	2.01	0.55	0.18	0.00	0.18	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	35.44	1.96	1.23	1.96	1.10	0.12	0.12	0.00	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	42.18	2.01	1.48	1.21	1.34	0.40	0.00	0.13	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	27.83	2.59	1.18	2.36	1.89	0.00	0.00	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	37.70	1.19	0.60	1.39	1.39	0.00	0.00	0.20	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	40.69	2.34	0.23	0.94	1.17	0.47	0.00	0.47	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	29.65	2.90	0.83	2.49	2.07	0.21	0.21	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	29.86	1.33	0.66	2.88	0.66	0.44	0.22	0.44	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	42.82	3.55	1.67	1.67	1.88	0.21	0.00	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	29.47	2.02	1.08	2.56	2.29	0.27	0.13	0.27	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	33.89	2.38	1.02	1.53	0.68	0.00	0.00	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	35.86	2.51	0.96	1.93	0.96	0.00	0.00	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	25.79	1.72	0.52	2.24	2.06	0.69	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	33.61	2.19	1.23	1.51	1.65	0.00	0.00	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	33.65	2.13	1.31	1.64	1.64	0.16	0.00	0.66	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	26.59	4.43	0.51	1.53	1.87	0.17	0.17	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	33.88	2.07	1.04	1.78	1.18	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	25.06	1.60	1.07	2.13	1.07	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	28.48	3.18	0.97	3.18	0.69	0.14	0.00	0.14	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	29.29	4.29	1.90	1.90	1.43	0.00	0.00	0.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	32.45	3.22	2.02	0.60	1.81	0.00	0.40	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	26.27	3.48	1.32	1.98	1.60	0.47	0.38	0.09	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	37.38	3.14	2.79	3.14	1.75	0.35	0.35	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	29.01	1.81	1.51	1.81	0.91	0.91	0.30	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	34.39	2.33	0.73	2.08	1.84	0.61	1.10	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	47.45	5.53	1.60	3.06	2.33	0.44	0.15	0.29	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	49.28	2.43	1.22	4.26	1.83	0.00	0.00	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	29.84	2.71	1.51	3.32	0.90	0.30	0.60	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	56.32	3.85	0.68	2.94	1.81	0.90	2.04	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	51.52	5.09	2.40	2.40	1.20	0.30	0.30	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	49.83	4.96	2.36	3.66	1.30	1.77	4.72	0.12	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	69.80	5.98	1.92	2.35	1.07	2.13	3.84	1.07	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	38.46	5.41	3.00	1.20	3.61	0.60	0.60	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	37.99	3.57	2.44	0.00	1.13	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	30.62	3.40	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	72.08	6.79	5.70	2.63	0.66	0.44	0.44	1.31	0.88	0.00
Sebocyte, donor1	11220-116B5	62.45	1.64	9.31	3.83	1.64	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	49.63	2.30	0.46	2.30	0.46	0.00	0.00	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	51.53	3.30	4.12	0.82	1.03	0.82	0.21	0.21	0.21	0.00
Sertoli Cells, donor1	11255-116F4	164.00	4.97	3.31	3.31	3.31	0.00	0.00	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	152.52	5.65	2.82	5.65	5.65	0.00	0.00	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	63.70	3.43	2.90	1.23	1.32	0.35	1.06	0.26	0.18	0.00
Skeletal Muscle Cells, donor2	11358-117H8	57.10	2.17	2.89	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	30.93	5.02	2.51	3.34	0.84	0.00	0.00	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	67.55	3.30	3.93	1.89	0.79	0.16	0.31	0.47	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	75.51	3.72	3.72	1.49	1.93	0.30	0.59	0.89	0.15	0.00
Skeletal Muscle Cells, donor6	11459-119B1	66.95	3.39	2.92	1.54	0.92	0.31	0.00	0.31	0.31	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	89.97	6.55	5.42	2.39	1.89	1.01	0.88	0.13	0.00	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	83.76	6.28	4.85	3.71	1.57	0.57	0.43	0.43	0.14	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	84.23	3.97	5.46	1.39	2.28	0.60	0.20	0.40	0.30	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	76.00	6.15	5.14	2.70	1.69	0.76	0.25	0.17	0.34	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	33.29	0.00	1.45	2.17	1.45	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	46.92	2.48	2.20	2.20	0.55	0.14	0.14	1.10	0.00	0.00
Skin - palm, donor1	10286-104F7	115.50	5.37	8.06	26.86	5.37	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	97.88	5.62	4.04	2.59	2.74	0.58	0.43	0.58	0.58	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	73.61	4.91	4.09	4.09	3.27	0.00	0.82	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	80.75	3.76	3.25	3.64	2.60	0.26	0.26	0.26	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	97.31	4.73	3.48	6.12	1.53	0.83	1.25	0.42	0.42	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	75.39	1.69	1.97	4.64	1.83	0.70	0.28	0.56	0.42	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	109.53	4.23	5.07	4.44	1.27	0.42	0.21	0.21	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	101.56	3.97	2.32	2.70	2.02	0.67	0.37	0.22	0.52	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	50.61	3.70	0.93	0.62	0.93	1.85	0.00	0.31	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	155.19	14.67	14.45	6.00	4.45	1.56	0.44	0.44	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	86.41	5.88	8.23	1.76	2.94	0.00	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	47.07	1.77	3.09	1.77	0.66	0.22	0.44	0.22	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	52.77	1.97	2.76	1.18	1.18	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	97.34	3.86	3.09	0.77	1.55	0.00	0.00	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	102.08	4.00	6.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	67.47	3.46	4.52	1.46	0.67	0.13	0.27	0.27	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	127.23	6.65	7.54	5.10	3.55	1.55	1.11	1.77	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	110.11	5.38	5.89	2.94	1.79	0.38	0.13	1.28	0.38	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	77.49	3.91	7.16	1.95	1.63	0.33	0.00	0.98	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	105.14	10.34	10.04	1.77	1.48	0.00	0.00	0.30	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	101.51	4.41	4.13	1.42	1.57	0.00	0.14	0.57	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	23.43	1.30	2.11	0.98	0.49	0.16	0.16	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	46.58	3.04	5.18	1.52	1.52	0.30	0.00	0.00	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	54.30	3.79	4.29	2.02	0.51	0.00	0.00	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	61.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	43.87	1.43	0.95	1.43	0.48	0.00	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	63.71	4.87	3.83	1.62	1.03	0.15	0.15	0.59	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	72.10	3.01	2.37	1.08	0.43	0.86	0.43	0.86	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	71.27	3.36	3.46	1.36	1.57	0.84	0.21	0.42	0.52	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	47.80	3.09	2.78	0.93	0.31	0.15	0.00	0.15	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	59.28	3.23	2.16	1.08	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	71.73	5.38	2.99	2.39	0.30	0.30	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	33.12	2.73	1.02	0.00	0.68	0.68	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	87.01	4.24	4.48	2.28	1.18	0.24	0.08	0.47	0.47	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	124.49	7.45	8.35	4.23	2.92	1.91	2.72	0.50	0.20	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	158.60	8.87	6.37	5.23	3.64	0.68	0.46	1.59	1.14	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	58.57	3.02	1.81	1.21	1.81	0.60	0.00	0.60	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	50.60	4.77	4.24	1.06	1.06	0.26	0.53	0.26	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	96.81	9.99	6.39	3.33	1.07	1.20	1.07	0.13	0.13	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	94.79	5.63	4.88	2.13	2.63	0.63	1.38	1.25	0.38	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	80.66	8.37	4.82	3.80	2.03	1.27	0.76	0.00	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	77.50	4.22	6.63	3.47	2.11	0.15	0.00	0.15	0.45	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	72.77	3.00	6.00	0.00	0.75	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	65.90	0.00	1.29	2.58	2.58	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	93.48	7.44	5.58	3.26	1.40	0.00	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	95.42	7.57	8.08	2.02	0.00	1.51	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	116.58	4.39	5.33	2.51	3.45	0.31	0.31	2.19	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	35.40	2.65	2.36	1.18	1.18	0.00	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	54.23	5.08	3.75	2.25	1.17	0.17	0.08	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	64.47	2.34	4.20	2.80	1.40	0.93	0.47	0.47	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	61.02	3.17	3.17	1.15	1.58	0.00	0.14	0.00	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	58.13	3.57	2.55	2.04	1.27	0.51	0.00	0.51	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	49.26	1.88	0.94	0.94	1.32	1.32	0.19	0.56	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	58.13	4.19	4.47	1.82	1.82	0.14	0.14	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	100.63	8.04	6.28	2.35	1.68	0.34	0.00	0.34	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	14.29	1.43	1.43	0.00	0.00	0.48	0.00	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	53.34	0.49	1.71	0.73	0.73	0.00	0.00	0.00	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	113.79	7.73	5.52	6.19	1.77	0.66	1.99	0.22	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	52.37	1.76	2.93	0.29	0.88	0.59	0.00	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	83.96	4.66	5.25	1.75	1.75	0.58	0.58	0.39	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	67.17	5.29	5.29	2.12	1.32	0.53	0.00	0.53	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	51.33	4.84	6.70	0.00	2.23	2.98	1.86	1.12	1.49	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	90.55	6.11	6.83	2.52	3.23	0.72	0.36	1.08	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	70.69	5.68	4.83	0.85	2.84	0.28	0.00	0.57	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	53.96	7.09	3.15	2.76	1.58	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	45.20	5.59	3.56	1.02	1.52	0.25	1.27	0.51	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	63.09	6.39	5.19	0.80	2.00	0.80	0.80	0.80	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	68.13	5.43	3.34	1.25	0.84	1.25	1.25	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	87.09	4.58	4.58	2.29	2.29	0.92	0.92	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	92.91	6.56	5.39	4.04	2.02	0.50	0.17	0.34	0.67	0.00
Synoviocyte, donor2	11368-117I9	111.97	5.36	6.37	1.68	1.84	1.01	1.01	0.50	0.34	0.00
Synoviocyte, donor3	11440-118H9	89.14	6.48	9.38	1.12	1.56	0.67	0.89	0.22	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	45.38	5.00	3.22	0.71	0.36	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	23.78	1.98	1.98	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	32.88	2.55	1.62	0.69	0.23	0.00	0.23	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	42.72	2.87	1.72	1.79	0.65	0.00	0.07	0.22	0.14	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	36.34	2.71	2.71	1.16	0.77	0.00	0.00	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	34.93	0.57	1.15	4.58	1.15	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	341.88	17.84	8.86	11.44	5.66	2.21	6.03	1.60	0.62	0.25
Urethra, donor2	10319-105A4	249.98	5.40	5.40	5.40	8.99	1.80	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	51.80	3.19	2.66	0.53	1.59	0.00	0.27	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	49.27	2.40	1.20	0.40	0.80	0.00	0.80	1.20	0.00	0.00
Urothelial Cells, donor3	11681-122H7	52.72	2.06	1.60	1.38	0.92	0.00	0.00	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	119.69	7.58	6.24	1.11	2.23	0.45	0.00	0.22	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	529.42	34.70	11.57	16.91	33.81	1.78	0.00	2.67	1.78	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	593.29	25.73	15.73	12.87	35.74	0.00	0.00	2.86	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	384.02	14.37	7.53	6.85	20.54	2.05	0.68	2.74	2.74	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	487.58	15.15	8.61	11.71	28.92	1.03	0.00	1.72	1.38	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	550.23	17.43	6.97	8.72	26.73	1.16	0.00	0.58	1.74	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	506.04	30.20	12.49	18.74	22.91	1.04	0.00	3.12	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	477.25	21.11	7.34	11.93	18.36	1.84	0.00	2.75	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	424.50	11.87	10.95	9.13	14.61	4.56	0.00	5.48	5.48	0.00
Wilms' tumor cell line:G-401	10809-111A8	70.44	4.56	5.06	3.45	2.10	0.62	0.62	0.74	0.12	0.37
Wilms' tumor cell line:HFWT	10597-108E3	95.92	3.52	8.80	1.76	2.64	0.00	0.00	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	51.39	3.35	3.63	1.12	0.28	0.28	0.00	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	138.46	4.13	6.20	8.27	8.27	0.00	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	112.69	5.61	2.80	1.78	3.06	0.25	0.00	0.25	0.76	2.04
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	181.79	6.73	2.32	5.34	3.25	0.46	0.00	0.23	0.70	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	252.02	18.04	4.87	2.49	2.73	0.47	0.71	0.36	0.36	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	116.46	5.71	3.81	1.63	2.45	0.27	0.54	0.27	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	78.42	2.81	2.25	1.41	1.41	0.28	0.28	0.28	0.84	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	273.87	11.21	9.52	3.81	3.60	0.85	0.42	1.06	0.21	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	227.02	4.36	4.36	15.24	2.18	1.09	0.00	1.36	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	172.29	7.93	3.97	2.64	3.08	0.00	0.00	1.32	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	204.18	6.94	3.27	4.08	4.49	0.82	1.23	2.04	0.82	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	307.14	5.44	5.05	3.88	5.82	1.16	0.39	3.11	1.94	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	32.57	1.29	0.74	1.84	0.92	0.00	0.00	0.37	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	171.62	7.80	0.00	3.90	3.90	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	187.53	7.44	3.02	4.65	8.13	0.23	0.23	0.46	1.16	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	159.22	7.25	5.95	3.62	3.37	0.26	0.26	0.52	1.04	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	224.74	5.84	7.01	7.89	3.21	0.29	0.29	1.75	2.34	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	179.40	5.58	4.65	5.11	5.58	0.93	0.00	0.93	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	82.25	3.29	1.23	6.17	4.11	0.00	0.41	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	258.15	14.12	8.59	7.67	10.44	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	160.87	7.68	6.83	7.25	3.84	0.00	0.00	1.71	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	151.65	8.19	3.94	3.64	3.64	0.30	0.61	0.00	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	146.83	12.52	4.33	4.33	6.26	0.24	0.00	0.48	0.00	3.61
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	87.31	6.68	1.56	1.11	1.56	0.22	0.00	0.00	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	86.39	5.34	2.00	1.33	2.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	113.35	1.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	135.22	7.91	4.90	1.88	2.64	0.38	0.75	0.38	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	157.44	4.80	5.23	3.05	3.49	0.44	0.44	0.00	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	208.07	7.50	5.62	3.75	0.00	0.00	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	290.84	9.18	7.30	17.19	12.48	0.71	0.94	0.94	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	159.93	6.98	3.72	5.89	8.38	0.78	2.17	1.09	1.09	0.16
adipose, donor1	10184-103D4	129.60	19.94	5.86	4.69	1.76	10.56	17.59	2.35	0.59	0.00
adipose, donor2	10185-103D5	179.64	40.55	25.14	4.46	6.08	8.92	5.68	0.41	0.81	0.00
adipose, donor3	10186-103D6	134.24	19.06	10.07	4.90	3.81	5.17	5.99	0.27	1.36	0.00
adipose, donor4	10187-103D7	77.14	3.47	1.73	4.33	2.60	2.60	1.73	0.00	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	124.84	12.15	6.31	5.05	1.74	0.63	0.16	0.32	0.32	0.16
adrenal gland, adult, pool1	10081-102A9	538.37	21.83	10.91	10.91	18.19	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	80.58	5.87	4.14	0.67	2.27	0.80	1.07	0.13	0.67	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	85.39	6.07	1.07	2.86	3.57	0.36	1.79	0.71	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	214.46	25.50	10.43	6.72	2.78	0.46	0.70	0.93	1.39	0.00
amniotic membrane cells, donor2	12236-129G4	185.62	18.26	7.78	2.03	2.37	2.37	1.01	0.34	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	202.10	19.44	11.19	2.95	3.24	0.88	0.29	0.29	0.59	0.00
amygdala - adult, donor10196	10167-103B5	539.54	48.62	43.87	39.13	45.06	2.37	0.00	3.56	2.37	3.56
amygdala, adult, donor10252	10151-102I7	405.94	32.04	27.78	21.90	14.60	2.43	1.22	2.84	2.43	0.00
amygdala, newborn, donor10223	10360-105E9	338.26	27.44	26.14	32.28	18.08	1.61	1.29	1.29	0.97	3.23
anaplastic carcinoma cell line:8305C	10428-106D5	81.75	6.11	3.69	1.15	1.53	0.38	0.38	0.13	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	142.08	4.63	6.18	1.32	3.75	0.22	0.22	0.66	0.66	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	163.34	10.02	8.02	15.70	3.34	0.00	0.00	1.34	0.33	0.00
aorta, adult, pool1	10052-101G7	249.29	11.77	11.96	3.33	10.59	1.37	0.39	1.96	0.20	0.98
appendix, adult	10189-103D9	234.81	12.03	4.66	8.54	5.05	1.94	1.55	1.94	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	156.83	8.60	5.85	3.78	4.82	0.69	0.69	0.69	0.00	1.72
artery, adult	10190-103E1	149.46	6.79	5.43	4.08	14.95	1.36	0.00	0.00	4.08	0.00
astrocytoma cell line:TM-31	10425-106D2	186.44	12.89	8.98	13.04	4.35	0.58	0.43	0.43	0.72	0.00
b cell line:RPMI1788	10427-106D4	89.96	5.80	4.16	1.04	1.64	0.00	0.00	0.00	0.15	1.19
basal cell carcinoma cell line:TE 354.T	10702-109G9	132.34	5.27	7.21	3.61	5.27	0.55	1.11	0.83	0.83	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	78.29	5.06	3.77	4.07	1.59	0.10	0.20	0.00	0.00	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	108.46	4.85	1.84	4.02	2.18	0.00	0.17	0.50	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	281.86	12.30	4.47	6.15	3.36	0.00	0.56	0.00	0.56	1.68
bladder, adult, pool1	10011-101C2	180.24	11.73	7.17	1.63	9.78	0.54	0.98	1.09	0.98	0.00
blood, adult, pool1	10053-101G8	655.53	17.72	11.07	11.07	19.93	2.21	0.00	2.21	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	91.63	6.85	4.28	0.00	0.86	0.86	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	149.14	4.72	4.05	3.37	5.40	2.70	0.00	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	439.75	26.65	26.65	21.53	21.53	9.23	3.08	3.08	2.05	0.00
brain, adult, pool1	10012-101C3	378.73	37.64	30.40	32.52	21.83	3.01	3.01	3.01	1.00	0.11
brain, fetal, pool1	10085-102B4	499.55	34.73	56.10	13.36	8.01	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	78.63	5.95	2.64	6.94	3.30	0.00	0.00	0.33	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	82.38	5.37	2.50	3.37	2.00	0.25	0.00	0.12	0.12	0.00
breast, adult, donor1	10080-102A8	376.29	8.84	10.73	2.53	3.79	1.26	0.63	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	58.95	4.57	3.56	11.94	1.27	0.51	0.13	0.25	0.64	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	176.87	9.28	4.64	11.75	4.64	0.00	0.62	0.00	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	90.94	8.52	7.37	3.22	1.15	0.23	0.69	1.15	0.46	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	52.77	4.12	0.48	3.15	0.97	0.00	0.00	0.00	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	110.49	11.75	7.99	2.82	3.29	0.47	0.00	0.00	0.47	0.94
carcinoid cell line:NCI-H727	10735-110B6	130.27	10.06	3.50	5.36	3.50	0.11	0.00	0.11	0.33	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	128.66	10.46	5.70	3.49	1.58	0.63	0.32	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	122.97	13.58	7.72	2.40	1.86	0.53	0.53	1.86	1.06	0.00
caudate nucleus - adult, donor10196	10177-103C6	385.69	39.14	28.78	34.54	20.72	1.15	0.00	1.15	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	345.53	28.45	23.09	27.11	17.07	1.34	1.00	3.01	1.51	0.00
caudate nucleus, adult, donor10258	10379-105H1	383.60	34.39	24.45	59.60	25.22	3.06	0.00	2.29	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	290.42	21.24	18.68	38.82	14.28	2.20	0.37	1.46	0.73	7.69
cerebellum - adult, donor10196	10173-103C2	425.34	32.05	61.18	14.57	32.05	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	306.60	21.56	24.77	7.26	12.60	1.28	0.21	1.49	0.64	0.00
cerebellum, adult, pool1	10083-102B2	341.50	20.70	35.87	10.00	18.28	0.69	0.69	2.41	1.38	0.00
cerebellum, newborn, donor10223	10357-105E6	133.68	20.76	17.44	1.66	3.32	1.66	1.66	1.66	0.00	0.83
cerebral meninges, adult	10188-103D8	387.54	37.82	30.00	32.53	17.90	1.01	1.51	3.28	1.51	0.00
cerebrospinal fluid, donor2	10294-104G6	105.98	6.58	5.12	8.04	13.16	1.46	0.73	1.46	0.00	1.46
cervical cancer cell line:D98-AH2	10552-107I3	107.26	5.90	3.59	3.74	5.18	0.43	0.58	0.14	0.29	0.29
cervical cancer cell line:ME-180	10553-107I4	79.05	7.95	0.99	5.30	1.49	0.00	0.00	0.50	0.00	0.17
cervix, adult, pool1	10013-101C4	189.51	13.96	10.71	4.41	10.50	1.47	2.20	0.52	0.42	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	194.80	12.54	8.08	9.75	2.65	0.84	1.25	0.84	1.11	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	177.65	6.53	9.14	3.92	3.92	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	108.99	7.08	4.60	2.86	1.86	2.61	1.99	0.50	0.25	0.25
choriocarcinoma cell line:SCH	10785-110H2	143.05	7.27	2.83	5.30	1.60	0.62	0.49	0.37	0.49	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	47.44	2.61	1.19	4.51	0.24	0.24	0.00	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	219.39	28.49	10.83	8.55	5.70	1.71	2.28	4.27	2.28	0.00
chorionic membrane cells, donor2	12239-129G7	139.10	9.74	5.77	2.19	2.59	3.38	3.68	0.50	0.99	0.00
chorionic membrane cells, donor3	12240-129G8	180.78	22.53	7.14	8.79	7.14	4.40	4.40	2.20	1.65	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	246.39	13.13	4.04	13.13	3.03	2.02	2.02	2.02	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	585.71	14.22	11.14	11.33	14.41	1.73	1.15	1.34	1.34	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	277.29	6.97	7.18	13.52	6.55	0.84	0.21	0.21	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	46.22	3.34	3.08	2.82	1.80	0.00	0.00	0.51	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	48.62	4.84	4.60	2.42	2.66	0.24	0.00	0.24	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	47.44	3.66	1.02	3.46	1.43	0.00	0.00	0.00	0.41	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	89.81	5.89	3.53	3.83	3.83	0.00	0.00	0.00	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	300.24	7.82	5.99	11.73	3.91	0.52	0.52	0.26	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	90.52	8.23	8.00	0.69	1.37	1.83	0.46	1.37	0.91	0.23
clear cell carcinoma cell line:TEN	10636-108I6	111.74	9.20	8.15	1.74	2.43	0.87	0.52	0.69	1.04	0.69
colon carcinoma cell line:CACO-2	10513-107D9	92.99	6.22	2.20	8.24	2.01	0.18	0.18	0.00	0.37	0.00
colon carcinoma cell line:COLO-320	10420-106C6	87.42	5.70	2.66	1.14	0.38	0.00	0.38	0.00	0.38	0.38
colon, adult, donor1	10082-102B1	243.96	4.76	15.47	4.76	3.57	0.00	0.00	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	187.30	7.99	6.35	4.94	4.82	1.65	0.82	0.47	0.12	0.12
colon, fetal, donor1	10070-101I7	418.38	15.45	9.27	6.18	13.60	1.85	0.62	1.85	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	577.52	9.17	0.00	4.58	27.50	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	375.55	0.00	0.00	0.00	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	220.12	7.65	8.50	5.52	5.95	1.27	0.85	0.42	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	145.65	6.34	5.13	10.26	4.38	0.75	0.60	0.60	0.45	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	144.68	6.77	3.24	9.73	4.37	0.85	0.28	0.71	0.14	0.00
corpus callosum, adult, pool1	10042-101F6	348.38	35.82	28.53	7.96	15.37	0.33	0.44	1.44	0.33	0.11
cruciate ligament, donor2	10295-104G7	121.57	4.05	4.86	0.00	3.24	1.62	0.81	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	178.97	5.62	8.03	3.21	8.03	0.80	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	281.99	30.00	24.96	18.48	17.76	2.64	2.16	2.88	0.96	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	78.76	2.53	1.38	2.30	2.98	0.69	0.00	1.38	0.69	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	99.50	8.21	3.85	5.64	3.33	0.00	0.51	0.26	0.00	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	119.40	8.91	4.33	1.69	1.69	0.24	0.72	0.72	0.48	0.00
ductus deferens, adult	10196-103E7	392.69	19.44	11.46	11.96	14.45	4.98	1.00	1.99	1.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	337.01	11.52	17.28	7.20	4.32	1.44	1.44	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	203.77	14.71	6.62	11.77	5.15	5.15	1.47	2.94	3.68	0.00
dura mater, adult, donor1	10041-101F5	152.62	9.33	7.52	6.19	6.69	0.25	0.50	0.58	0.25	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	88.83	20.65	1.55	9.33	2.00	2.00	1.55	0.44	0.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	133.12	16.05	7.45	3.01	2.87	0.86	1.15	0.29	0.72	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	47.48	1.23	1.85	1.85	0.62	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	54.79	1.82	1.82	0.91	1.82	0.00	0.00	0.91	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	60.82	2.47	2.47	0.93	0.62	0.62	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	38.09	3.94	3.94	3.94	0.00	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	58.99	6.37	4.02	1.01	0.34	0.00	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	78.11	7.97	7.43	1.99	1.63	0.36	0.36	0.72	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	112.73	8.20	7.72	2.09	3.38	0.96	0.16	1.93	1.77	0.00
epidermoid carcinoma cell line:A431	10426-106D3	96.15	7.11	3.45	3.78	1.11	0.11	0.11	0.11	0.22	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	88.98	6.05	2.86	3.74	1.54	0.00	0.11	0.33	0.11	0.11
epididymis, adult	10197-103E8	341.80	15.49	11.51	23.02	11.93	7.54	7.54	4.60	2.09	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	124.54	12.06	7.27	1.77	2.84	0.35	0.18	0.35	0.18	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	71.18	3.54	3.54	1.18	1.18	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	90.82	6.55	2.62	4.46	2.36	0.39	0.13	0.52	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	87.40	4.72	2.26	5.51	2.17	0.20	0.10	0.20	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	100.15	7.06	1.68	7.73	3.81	0.34	0.00	0.90	0.90	0.11
esophagus, adult, pool1	10015-101C6	109.58	6.26	4.25	2.55	4.35	0.96	0.85	0.42	0.21	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	125.24	9.27	10.77	3.88	3.63	0.13	0.13	0.38	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	96.58	12.07	7.24	0.00	4.83	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	113.63	4.21	10.52	2.10	6.31	0.00	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	116.08	4.46	4.46	1.49	5.95	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	146.75	10.32	6.88	3.44	5.73	1.15	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	145.74	7.29	4.37	7.29	17.49	1.46	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	323.39	24.41	18.30	5.85	11.69	1.53	1.02	1.53	1.53	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	70.27	3.33	2.31	4.62	2.05	0.26	0.13	0.26	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	104.94	7.36	3.80	1.42	2.85	0.71	0.24	0.71	0.71	0.47
frontal lobe, adult, pool1	10040-101F4	487.04	46.72	41.00	45.32	21.86	1.03	1.03	1.50	0.66	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	68.46	5.40	2.10	6.31	1.20	0.00	0.30	0.30	0.00	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	103.87	13.62	9.69	3.11	1.55	0.37	0.18	0.37	0.09	0.09
gall bladder, adult	10198-103E9	246.26	10.14	6.28	5.79	9.66	1.69	1.69	1.93	1.21	0.00
gamma delta positive T cells, donor1	11937-126A2	586.25	20.40	7.52	19.86	33.28	2.15	1.61	0.54	3.22	3.22
gamma delta positive T cells, donor2	11938-126A3	476.95	14.94	8.59	41.08	33.99	2.24	1.12	1.87	3.36	3.73
gastric adenocarcinoma cell line:MKN1	10614-108G2	70.34	3.38	1.90	4.01	0.63	0.63	1.06	0.42	0.84	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	84.33	3.48	2.32	5.61	1.93	0.19	0.19	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	111.49	6.39	4.75	3.44	0.98	0.00	0.00	0.00	0.16	0.66
gastric cancer cell line:GSS	10560-108A2	133.62	10.98	10.07	8.24	6.41	0.92	0.92	0.92	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	169.06	8.68	3.66	7.31	3.43	2.74	0.46	1.14	0.69	1.37
giant cell carcinoma cell line:LU65	10487-107B1	73.66	2.29	1.03	2.29	0.80	0.11	0.00	0.11	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	121.48	10.64	10.64	1.26	1.68	0.56	0.42	0.00	0.14	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	70.83	4.74	0.75	2.24	1.75	0.50	0.25	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	76.21	6.76	6.23	1.06	1.16	0.00	0.32	0.00	0.11	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	92.41	12.36	6.88	0.42	1.40	0.00	0.00	0.14	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	121.30	11.70	8.50	1.88	1.88	0.22	0.22	0.44	0.33	0.33
glioma cell line:GI-1	10413-106B8	350.87	15.82	13.77	6.15	5.27	1.76	3.51	1.17	0.88	0.00
globus pallidus - adult, donor10196	10175-103C4	447.55	55.40	29.16	24.05	32.80	1.46	0.73	0.73	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	420.82	32.22	22.46	6.35	15.62	3.66	0.98	3.66	1.46	0.00
globus pallidus, adult, donor10258	10367-105F7	258.78	36.97	21.91	26.01	21.91	6.85	1.37	5.48	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	243.54	30.38	15.45	13.86	14.92	3.20	0.00	2.66	0.00	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	631.36	12.24	7.34	19.58	26.92	0.00	0.00	0.00	0.00	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	153.00	0.00	0.00	10.93	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	240.42	10.45	0.00	10.45	5.23	0.00	0.00	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	149.76	5.44	6.08	2.56	2.56	0.96	0.32	1.60	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	77.13	6.43	4.59	3.67	3.21	0.46	0.92	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	75.45	5.94	3.66	7.77	1.83	0.00	0.91	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	93.39	8.37	2.58	6.44	2.58	0.00	0.00	0.64	0.00	0.64
hIPS, biol_rep1	14380-156B6	34.49	11.50	7.19	7.19	2.87	1.44	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	105.62	5.49	6.17	10.29	3.43	0.00	0.69	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	379.59	51.86	23.17	32.00	32.00	2.21	0.00	2.21	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	104.88	5.17	3.45	1.72	2.30	0.57	0.29	0.00	0.86	0.29
heart - mitral valve, adult	10205-103F7	189.25	11.06	14.65	1.20	9.57	0.00	0.60	0.90	1.49	0.00
heart - pulmonic valve, adult	10206-103F8	160.81	7.84	5.23	2.88	7.32	0.52	0.78	0.26	1.05	0.00
heart - tricuspid valve, adult	10207-103F9	180.68	5.83	3.33	0.83	1.67	0.83	0.00	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	150.19	9.39	6.53	4.08	5.51	0.41	0.41	0.20	0.82	0.20
heart, adult, diseased, donor1	10051-101G6	227.39	10.22	10.65	2.55	12.35	1.28	0.85	2.55	2.55	0.00
heart, adult, pool1	10016-101C7	192.03	10.58	8.28	2.53	7.59	0.00	0.00	0.46	0.00	0.23
heart, fetal, pool1	10046-101G1	234.32	16.22	8.52	4.11	6.37	0.41	0.21	0.72	0.51	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	232.01	8.64	11.11	4.94	5.86	0.62	0.31	0.93	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	29.73	4.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	103.53	5.30	2.21	3.43	1.77	0.33	0.00	0.88	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	108.75	4.98	3.40	3.03	0.97	0.12	0.24	0.36	0.24	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	105.40	7.17	2.63	3.33	1.01	0.10	0.30	0.30	0.10	0.00
hepatoma cell line:Li-7	10484-107A7	184.51	6.78	2.56	4.67	2.34	0.33	0.22	0.56	0.44	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	99.70	3.82	2.91	6.13	2.11	0.00	0.00	0.00	0.00	0.40
hippocampus - adult, donor10196	10169-103B7	562.12	53.94	39.75	49.21	31.23	4.73	0.95	3.79	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	395.34	37.55	23.27	14.29	18.37	2.25	0.41	3.47	1.84	0.00
hippocampus, adult, donor10258	10374-105G5	355.04	48.30	30.87	58.26	35.35	1.00	0.00	1.49	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	364.46	23.97	27.14	46.88	15.86	2.82	0.70	0.70	0.35	4.23
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	137.94	9.16	5.49	9.77	1.83	3.66	6.71	3.66	3.66	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	135.48	7.46	4.91	2.95	1.18	0.59	0.98	0.39	0.59	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	115.78	5.84	4.32	6.35	2.54	2.29	2.54	0.76	0.25	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	100.37	10.71	6.20	2.26	1.13	10.15	6.77	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	110.00	10.07	4.91	2.84	2.58	13.17	9.81	5.42	5.16	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	120.72	13.67	8.35	5.31	2.66	11.01	11.77	0.76	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	130.21	17.52	8.17	6.42	3.50	12.55	9.93	1.17	0.58	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	158.99	23.48	9.69	7.11	4.31	14.65	10.13	1.29	0.43	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	138.89	20.85	11.26	5.42	2.50	13.76	10.01	0.83	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	152.73	18.23	11.13	5.92	4.26	4.97	6.16	1.42	0.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	143.20	15.43	9.80	4.82	2.73	8.20	8.36	1.61	0.80	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	173.04	26.93	13.47	8.75	6.06	5.39	5.39	0.00	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	104.53	5.95	5.32	3.91	0.78	2.19	1.41	1.25	0.31	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	110.54	2.95	2.95	3.44	1.47	3.93	1.97	0.98	2.95	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	86.40	9.60	3.49	6.98	0.87	1.75	6.11	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	167.62	16.80	10.50	4.20	2.10	9.16	7.83	0.95	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	149.57	12.21	6.98	1.74	1.74	8.72	7.41	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	115.94	18.99	6.00	1.00	2.50	13.99	10.99	2.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	173.89	38.06	22.98	4.71	5.84	19.59	10.55	2.45	1.13	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	189.16	43.20	22.74	1.82	8.18	19.55	8.18	3.64	0.45	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	172.59	39.47	20.99	4.39	6.58	10.02	12.84	1.88	1.57	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	174.57	20.41	16.00	4.57	5.55	8.00	7.84	1.31	0.98	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	166.06	21.48	20.90	4.35	4.94	11.03	10.16	0.58	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	154.24	23.91	14.65	2.99	6.28	9.86	8.97	4.18	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	121.75	8.31	6.84	2.77	3.14	3.51	2.77	2.03	0.55	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	141.22	7.42	5.14	4.56	2.57	2.00	1.43	0.57	0.57	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	124.53	7.76	4.90	7.76	1.22	2.86	2.45	1.22	0.82	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	128.51	13.03	6.69	3.17	3.87	10.56	10.21	2.82	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	125.75	13.94	7.60	2.53	2.53	10.77	8.24	1.58	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	123.77	15.74	7.57	3.33	2.12	8.17	7.26	0.61	0.61	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	153.07	28.96	16.55	3.62	5.69	5.17	6.21	1.03	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	177.33	28.56	12.62	3.98	3.32	7.97	5.98	1.33	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	118.00	15.39	10.52	3.08	3.59	2.82	4.62	1.28	0.77	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	148.53	15.85	14.32	4.35	4.35	8.18	6.14	2.56	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	206.72	33.32	16.66	6.06	6.82	12.12	3.79	1.51	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	150.89	15.12	14.79	5.04	3.36	5.04	6.39	1.68	0.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	101.19	7.97	7.00	4.59	0.97	5.07	2.66	0.24	0.72	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	101.61	6.24	4.46	6.68	2.67	2.67	0.89	1.34	0.00	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	107.81	10.24	6.83	1.46	3.41	3.90	2.44	0.98	0.98	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	122.25	12.84	5.50	3.36	1.83	8.86	9.78	3.06	0.92	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	198.45	39.04	9.76	9.76	3.25	32.53	71.57	6.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	92.00	13.90	7.28	3.64	2.98	13.90	10.92	2.65	0.99	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	140.11	21.89	12.59	3.28	3.83	9.30	11.49	0.00	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	116.16	19.54	9.77	3.62	5.79	9.05	7.60	1.81	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	109.25	17.44	10.68	1.07	4.63	12.10	9.25	1.42	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	128.89	16.71	14.32	4.77	4.77	8.35	9.55	2.39	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	147.07	22.89	13.81	3.79	3.93	10.02	10.56	0.54	0.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	111.80	9.97	7.00	1.35	2.69	3.77	2.16	0.27	0.27	0.00
immature langerhans cells, donor1	11904-125F5	228.83	8.48	6.05	24.94	20.34	1.21	1.70	2.66	0.48	0.24
immature langerhans cells, donor2	11905-125F6	308.93	5.54	5.54	24.56	15.05	2.38	1.58	3.96	0.79	0.00
insula, adult, pool1	10039-101F3	486.42	50.72	41.73	51.67	22.71	1.23	0.76	1.61	0.95	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	151.52	8.13	2.28	7.15	2.28	1.30	0.98	0.33	0.98	0.00
kidney, adult, pool1	10017-101C8	226.69	12.92	11.71	6.01	8.41	0.80	1.30	0.80	0.70	0.00
kidney, fetal, pool1	10045-101F9	178.75	15.70	9.48	3.11	5.38	0.35	0.00	0.28	0.21	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	172.27	11.65	8.10	3.12	2.98	0.99	1.14	0.28	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	105.48	3.46	1.11	5.81	2.07	0.55	0.41	0.41	0.55	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	77.07	6.79	3.49	1.65	1.65	0.00	0.00	0.18	0.00	0.00
left atrium, adult, donor1	10079-102A7	189.61	7.63	5.45	2.72	7.08	0.54	0.54	1.09	0.54	0.00
left ventricle, adult, donor1	10078-102A6	196.19	7.58	9.10	8.60	17.70	1.52	1.52	1.52	1.52	0.00
leiomyoblastoma cell line:G-402	10721-110A1	91.11	4.38	4.65	2.46	1.09	0.27	0.27	0.27	0.00	0.82
leiomyoma cell line:10964C	10569-108B2	86.22	7.18	7.18	1.80	3.59	2.51	2.16	1.08	1.08	0.00
leiomyoma cell line:15242A	10570-108B3	145.11	4.35	6.52	3.26	5.43	2.17	1.09	3.26	1.63	0.00
leiomyoma cell line:15425	10571-108B4	84.26	4.61	5.58	1.21	1.21	0.97	0.97	2.67	1.21	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	279.37	19.05	6.35	19.05	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	80.51	12.55	2.09	0.00	3.14	0.00	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	242.61	7.44	6.02	10.39	4.25	0.59	0.24	0.12	0.47	0.24
liposarcoma cell line:KMLS-1	10782-110G8	168.24	12.81	7.81	5.94	3.44	0.62	0.78	0.62	1.09	0.16
liposarcoma cell line:SW 872	10726-110A6	153.27	9.26	5.24	13.04	4.51	0.12	0.12	0.37	0.49	0.37
liver, adult, pool1	10018-101C9	390.57	15.40	7.94	9.72	7.62	6.64	9.72	0.49	0.49	0.00
liver, fetal, pool1	10086-102B5	238.94	7.53	4.70	9.41	6.58	0.00	0.94	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	401.60	31.21	33.54	7.58	21.29	1.60	0.87	1.60	0.58	0.15
locus coeruleus, adult, donor10252	10165-103B3	424.10	32.85	23.07	5.91	19.56	1.85	1.48	2.03	2.40	0.18
locus coeruleus, adult, donor10258	10375-105G6	874.35	73.92	80.13	16.65	56.15	11.57	2.26	10.72	4.80	1.69
locus coeruleus, newborn, donor10223	10362-105F2	236.81	25.66	19.35	11.36	7.15	4.21	5.05	4.21	1.68	1.26
lung adenocarcinoma cell line:A549	10499-107C4	172.44	12.59	5.81	3.88	1.80	0.00	0.00	0.14	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	82.73	11.72	4.83	0.69	4.14	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	43.10	3.95	2.77	1.32	0.79	0.13	0.00	0.13	0.00	0.00
lung, adult, pool1	10019-101D1	261.18	17.84	7.56	1.89	8.39	1.42	2.36	0.95	0.12	1.77
lung, fetal, donor1	10068-101I5	374.74	35.96	17.41	5.71	11.42	0.86	2.28	1.43	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	351.91	15.58	15.12	7.79	10.08	5.96	4.58	2.29	1.37	0.00
lymph node, adult, donor1	10077-102A5	473.36	9.47	6.63	12.31	14.20	2.37	3.31	0.95	0.95	0.95
lymphangiectasia cell line:DS-1	10727-110A7	222.47	7.89	6.36	3.29	3.95	0.66	0.22	0.00	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	38.79	1.21	1.06	1.36	0.75	0.15	0.15	0.45	0.00	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	60.31	2.55	1.70	9.34	0.00	0.00	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	166.50	11.99	7.55	8.44	11.99	0.44	0.00	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	160.83	12.45	7.06	2.08	8.51	0.83	0.42	0.21	0.21	0.00
mature adipocyte, donor3	12233-129G1	129.91	11.14	7.82	2.13	5.22	0.95	1.19	0.24	0.24	0.00
mature adipocyte, donor4	12234-129G2	151.61	12.37	5.79	2.37	4.74	1.84	1.05	0.00	0.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	208.95	14.06	7.62	4.29	4.05	0.95	0.95	0.24	0.24	3.34
medial frontal gyrus - adult, donor10196	10170-103B8	530.17	31.58	34.97	34.97	40.61	0.00	0.00	3.38	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	356.59	24.28	17.10	18.39	15.63	1.84	0.55	1.66	2.21	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	480.98	39.08	40.03	47.65	33.99	5.08	0.64	2.54	2.22	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	206.85	27.30	18.34	71.22	9.81	3.41	0.85	8.96	4.26	5.12
medial temporal gyrus - adult, donor10196	10183-103D3	508.95	38.81	37.29	34.59	23.12	9.28	5.06	12.49	14.85	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	331.49	27.16	21.65	17.83	15.49	1.27	1.49	1.27	2.55	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	258.12	52.01	44.30	42.38	61.64	5.78	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	330.13	28.71	43.06	71.77	28.71	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	331.65	30.87	26.92	72.50	15.79	1.44	1.08	0.72	1.44	6.46
medulla oblongata - adult, donor10196	10174-103C3	418.59	55.16	31.15	4.54	24.66	1.30	0.65	0.65	0.00	1.95
medulla oblongata, adult, donor10252	10155-103A2	352.33	26.47	23.07	3.87	10.22	2.79	1.55	2.79	1.08	0.15
medulla oblongata, adult, pool1	10038-101F2	313.61	34.04	25.22	7.84	14.37	0.65	0.33	0.65	0.33	0.24
medulla oblongata, newborn, donor10223	10361-105F1	315.93	32.64	27.08	10.42	7.99	2.08	1.39	2.08	0.69	1.74
medulloblastoma cell line:D283 Med	10838-111E1	124.43	5.31	4.87	2.66	1.11	0.89	0.22	0.44	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	103.57	5.50	4.16	1.47	2.93	0.00	0.12	0.00	0.12	0.12
melanoma cell line:COLO 679	10514-107E1	68.85	5.17	3.74	2.44	1.29	1.44	0.86	0.29	0.14	0.14
melanoma cell line:G-361	10465-106H6	89.58	7.06	8.42	7.33	2.17	1.63	3.53	0.54	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	69.29	3.80	3.26	0.90	0.90	1.09	0.54	1.81	0.54	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	25.55	2.64	0.00	0.88	0.00	0.88	0.00	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	95.13	13.48	3.89	1.30	1.56	0.52	0.00	1.04	0.26	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	121.67	7.83	6.14	5.06	2.92	1.23	0.31	0.77	0.31	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	109.61	4.73	4.18	2.00	3.64	0.73	0.55	0.00	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	80.75	2.48	4.97	2.48	1.24	0.83	0.41	0.41	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	92.15	4.21	2.53	3.37	2.81	0.42	0.70	0.14	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	102.83	3.85	3.85	1.73	1.35	0.19	0.39	0.58	0.00	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	81.21	7.63	4.16	4.16	0.00	0.69	0.69	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	269.98	6.87	7.55	6.18	7.38	2.57	3.60	2.23	1.72	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	74.53	4.14	2.19	2.88	1.61	0.46	0.58	0.35	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	114.33	6.10	6.37	3.58	2.12	0.40	0.27	0.27	0.53	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	148.68	6.48	5.40	10.40	2.57	0.95	1.08	0.95	0.81	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	123.20	5.55	3.98	2.85	1.42	0.57	0.14	0.57	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	202.88	8.56	10.21	4.94	9.55	1.32	2.31	1.98	0.66	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	119.55	6.09	6.37	4.29	1.80	0.28	0.14	0.55	0.42	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	125.32	6.98	3.84	2.79	2.79	0.35	1.75	0.70	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	134.75	8.57	6.33	4.08	2.45	0.82	0.20	1.43	0.82	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	158.16	5.75	6.47	6.11	4.67	0.72	0.36	1.44	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	124.04	5.69	5.17	3.41	2.59	0.52	0.52	0.31	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	131.55	4.79	5.93	6.84	5.47	1.14	0.00	1.82	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	122.09	12.59	5.03	5.03	2.94	0.84	0.84	1.68	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	125.83	5.83	5.68	5.08	2.84	1.34	0.75	0.60	0.30	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	161.06	6.91	4.29	2.80	3.68	0.88	0.44	0.61	0.35	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	205.06	7.73	7.73	1.84	6.63	0.74	0.74	1.47	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	123.33	6.01	4.58	3.72	4.58	0.86	0.57	1.43	0.86	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	78.31	6.74	6.32	3.79	2.53	1.26	0.42	4.63	2.11	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	70.33	3.65	7.31	2.28	0.91	0.91	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	61.64	6.91	6.14	3.58	1.79	1.53	1.02	0.26	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	77.48	3.93	6.02	4.71	0.79	0.52	1.31	0.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	72.09	4.31	3.39	4.31	0.92	0.62	0.31	0.92	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	71.55	4.71	3.29	3.06	1.88	1.18	0.94	1.65	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	73.11	6.09	3.72	4.40	1.69	0.68	0.34	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	72.31	3.93	4.72	3.14	1.96	0.79	0.39	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	78.78	5.10	6.02	4.17	0.46	1.39	0.93	0.93	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	88.83	6.35	5.48	2.88	3.17	0.87	0.29	0.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	78.31	7.14	2.90	3.35	1.56	0.67	0.67	0.00	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	72.59	5.53	4.57	3.85	3.12	0.24	1.20	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	86.53	5.87	5.13	3.67	2.93	0.00	1.47	2.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	72.50	5.03	2.35	4.36	2.01	1.01	0.00	1.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	74.51	5.32	4.50	4.50	2.05	0.41	1.23	1.23	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	82.48	7.30	6.01	2.15	0.43	0.86	0.86	0.86	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	79.30	5.47	0.00	5.47	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	15.49	5.16	5.16	5.16	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	70.80	5.20	4.55	2.60	1.95	1.30	0.65	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	87.30	7.27	5.82	5.82	2.91	4.36	2.91	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	95.42	4.80	5.33	1.60	1.60	0.53	0.53	2.13	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	85.87	9.00	3.27	2.45	3.27	0.00	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	86.68	6.22	2.72	7.77	2.72	0.39	0.39	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	86.05	8.39	10.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	68.55	3.97	4.97	5.96	0.99	0.00	0.00	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	71.51	4.77	9.53	9.53	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	80.64	5.34	5.93	3.56	2.96	1.78	2.96	2.96	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	96.26	2.44	13.40	3.66	0.00	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	81.71	5.07	4.43	6.97	1.27	0.00	0.00	1.90	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	105.89	6.21	5.86	2.76	4.83	0.69	0.34	1.03	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	103.16	6.45	0.00	0.00	0.00	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	139.71	0.00	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	113.65	0.00	3.44	6.89	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	96.16	3.26	2.44	2.04	2.04	0.41	0.00	0.81	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	119.96	2.38	4.77	0.79	1.59	0.00	0.00	2.38	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	100.81	2.95	3.54	0.59	1.77	0.59	0.59	1.77	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	95.38	5.61	2.49	0.62	1.25	0.62	0.00	0.94	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	89.56	1.34	9.36	1.34	0.00	0.00	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	80.42	1.18	4.73	1.18	1.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	84.74	5.14	2.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	84.67	2.75	7.57	3.44	1.38	0.00	0.00	0.69	4.13	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	128.16	7.92	4.95	2.47	3.96	0.99	0.99	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	98.69	6.73	4.49	1.12	3.36	1.12	2.24	2.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	125.94	7.63	5.72	1.27	1.91	2.54	0.00	0.64	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	163.61	9.27	6.45	4.43	2.82	1.61	0.81	0.40	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	165.72	15.26	2.18	8.72	0.00	6.54	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	116.57	5.07	5.07	11.40	5.07	1.27	3.80	2.53	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	233.65	6.68	7.89	5.46	6.07	3.03	0.61	1.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	325.37	13.56	4.52	4.52	0.00	0.00	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	266.05	10.71	9.06	4.12	4.12	4.12	0.82	4.94	3.29	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	128.38	9.72	7.94	2.38	2.98	0.79	0.40	0.60	0.99	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	101.57	4.87	4.22	1.95	2.92	1.30	0.65	1.30	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	131.40	4.07	5.09	3.06	5.09	2.04	1.02	2.04	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	91.30	4.64	6.19	0.77	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	93.55	12.05	7.09	0.71	0.47	0.24	0.47	0.00	0.00	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	184.41	12.05	5.79	4.87	5.10	0.23	0.23	0.23	0.93	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	38.46	4.27	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	76.86	4.62	3.90	2.16	1.03	0.31	0.51	2.16	0.41	0.00
mesothelioma cell line:Mero-25	10850-111F4	54.47	5.90	2.27	1.82	3.18	0.68	0.23	0.00	0.45	0.00
mesothelioma cell line:Mero-41	10851-111F5	55.74	4.89	3.91	0.98	1.22	0.00	0.00	0.73	0.73	0.00
mesothelioma cell line:Mero-48a	10852-111F6	70.41	4.87	2.21	1.33	1.77	0.66	0.66	0.00	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	85.94	7.36	1.31	2.89	2.37	0.00	0.79	0.00	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	41.53	2.89	2.21	0.68	1.87	0.68	0.17	0.34	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	92.52	8.85	4.55	1.26	1.77	0.76	0.00	0.25	0.76	0.00
mesothelioma cell line:Mero-95	10856-111G1	128.78	9.52	6.63	7.25	6.83	1.45	0.62	1.45	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	41.58	2.82	2.82	1.99	1.49	0.66	0.00	0.17	0.33	0.00
mesothelioma cell line:NCI-H226	10846-111E9	76.38	3.08	2.17	4.34	1.27	0.18	0.00	0.54	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	51.42	4.61	3.07	3.76	4.27	0.17	0.68	0.17	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	39.44	5.34	4.58	0.25	1.02	0.00	0.00	0.51	0.25	0.00
mesothelioma cell line:No36	10857-111G2	48.93	3.26	2.61	0.00	1.96	0.33	0.00	0.98	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	56.09	1.90	1.90	1.63	2.17	0.27	0.00	0.54	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	100.76	7.48	5.37	5.18	4.61	0.38	1.34	1.34	0.58	0.19
migratory langerhans cells, donor2	11902-125F3	81.45	3.79	3.79	4.64	3.79	0.61	0.24	0.37	0.00	0.61
migratory langerhans cells, donor3	11903-125F4	85.61	4.67	2.33	3.41	2.33	0.18	1.08	0.00	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	107.09	3.92	4.24	0.98	1.63	1.31	0.00	2.61	0.98	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	160.86	7.84	5.09	11.02	2.76	0.85	0.64	1.06	1.06	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	50.45	2.07	0.92	1.61	0.46	0.23	0.00	0.46	0.00	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	144.62	4.00	3.43	7.23	6.85	0.95	1.14	0.00	0.38	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	224.34	10.16	6.10	6.10	2.59	0.18	0.37	1.11	0.18	1.11
myeloma cell line:PCM6	10474-106I6	112.67	4.55	5.53	6.92	4.35	0.20	0.79	0.20	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	94.86	9.13	2.54	1.52	1.01	0.51	0.00	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	53.15	1.77	2.75	1.77	1.57	0.00	0.39	0.20	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	101.62	7.47	2.90	2.12	0.45	0.22	0.33	0.67	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	88.62	7.72	3.02	1.69	1.62	0.15	0.51	0.37	0.29	0.00
nasal epithelial cells, donor2	12227-129F4	88.32	6.07	2.76	2.76	2.21	0.00	0.55	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	251.00	23.24	8.05	5.98	5.29	0.23	0.46	0.46	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	201.87	14.22	10.48	3.18	2.99	0.56	0.19	0.19	0.00	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	54.62	7.17	2.11	2.32	1.48	0.00	0.00	0.42	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	196.79	20.50	7.83	2.42	5.22	0.56	0.37	0.19	0.00	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	157.76	7.12	2.14	1.42	2.37	0.95	0.71	1.19	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	300.61	12.83	7.13	6.18	5.38	1.58	0.95	2.22	0.48	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	126.79	2.82	6.04	0.60	0.40	0.40	0.20	0.20	0.60	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	221.88	17.17	12.72	5.09	5.72	0.00	0.00	0.64	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	134.41	6.39	5.06	1.60	2.13	0.27	0.00	0.27	1.06	0.00
neutrophil PMN, donor1	12133-128D9	252.87	29.75	29.75	0.00	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	185.93	0.00	0.00	13.28	39.84	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	236.77	18.94	0.00	0.00	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	274.31	14.54	10.49	12.35	12.01	0.68	1.01	1.01	1.01	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	418.67	36.82	19.21	2.40	5.60	0.00	0.80	1.60	0.80	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	166.07	7.69	15.39	3.21	4.49	1.28	0.00	1.60	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	148.99	11.56	8.41	4.47	2.63	1.05	1.31	5.52	1.05	0.00
nucleus accumbens, adult, pool1	10037-101F1	413.58	40.21	31.40	43.87	17.53	0.94	0.94	1.22	0.00	0.19
occipital cortex - adult, donor10196	10172-103C1	523.34	45.33	32.97	37.09	30.91	2.06	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	333.31	21.20	16.37	8.59	12.88	2.15	0.54	2.15	1.88	0.00
occipital cortex, newborn, donor10223	10355-105E4	282.42	25.84	17.47	75.70	11.65	1.46	0.36	1.82	0.73	1.46
occipital lobe, adult, donor1	10076-102A4	650.22	44.35	42.77	39.36	28.60	5.77	3.67	7.61	5.77	0.26
occipital lobe, fetal, donor1	10073-102A1	506.34	33.04	46.34	11.16	18.45	1.29	0.43	3.00	1.29	0.00
occipital pole, adult, pool1	10036-101E9	341.46	30.67	26.25	27.75	16.40	0.63	0.24	0.39	0.32	0.08
olfactory region, adult	10195-103E6	326.32	32.10	30.00	29.23	22.16	2.48	1.53	2.87	1.53	0.38
optic nerve, donor1	10277-104E7	422.22	34.02	36.02	6.00	32.02	4.00	6.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	118.58	6.15	4.44	2.85	1.94	0.68	1.03	0.46	0.11	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	75.15	7.14	6.18	0.82	1.79	0.14	0.00	0.14	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	61.80	3.73	2.88	3.22	1.19	0.34	0.17	0.51	0.34	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	51.98	4.16	2.43	6.58	1.27	0.46	0.23	0.12	0.00	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	130.52	11.46	6.47	4.70	2.06	1.47	0.00	0.59	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	148.56	3.74	2.80	1.87	5.61	0.93	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	243.02	11.03	6.57	3.82	2.33	0.42	1.06	0.64	0.64	0.42
ovary, adult, pool1	10020-101D2	231.92	15.99	8.47	2.27	9.17	0.79	1.75	0.70	0.17	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	92.76	4.40	3.67	2.75	0.73	0.55	0.00	0.18	0.37	0.00
pancreas, adult, donor1	10049-101G4	468.44	28.22	15.05	7.53	9.41	1.88	0.00	3.76	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	67.65	2.80	1.12	3.07	1.68	0.56	0.28	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	63.71	4.26	2.56	1.53	1.36	0.17	0.00	0.85	0.17	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	92.56	7.62	2.81	1.99	1.16	0.17	0.33	0.33	0.00	0.99
paracentral gyrus, adult, pool1	10035-101E8	444.34	40.73	37.52	35.79	21.42	0.92	1.19	1.19	0.73	0.18
parietal cortex, adult, donor10258	10373-105G4	259.10	29.36	26.42	45.51	15.41	1.47	0.73	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	398.76	36.68	17.87	27.27	18.81	1.88	0.94	3.76	3.76	0.00
parietal lobe, adult, donor10252	10157-103A4	332.64	24.23	20.24	11.69	19.67	2.28	0.57	1.71	2.85	0.00
parietal lobe, adult, pool1	10034-101E7	405.79	36.48	31.46	32.87	18.59	0.53	0.62	0.70	0.79	0.00
parietal lobe, fetal, donor1	10072-101I9	460.67	36.85	33.94	8.73	20.37	1.94	3.88	6.79	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	287.87	25.05	22.43	75.52	13.09	2.62	1.50	2.62	1.87	3.36
parotid gland, adult	10199-103F1	667.85	24.05	21.58	15.42	19.73	4.32	3.08	0.62	1.23	0.00
penis, adult	10200-103F2	127.83	8.59	6.45	1.61	9.67	1.61	0.00	2.15	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	205.83	10.41	3.16	1.49	1.49	2.05	0.74	1.12	0.19	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	135.06	6.26	5.10	8.01	2.33	0.29	0.00	1.46	0.15	0.29
pineal gland - adult, donor10196	10179-103C8	408.30	45.15	32.90	29.67	23.22	1.29	0.65	0.00	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	595.17	50.93	42.64	20.14	21.91	2.37	0.59	1.78	3.55	0.00
pineal gland, adult, donor10258	10377-105G8	390.67	49.54	33.86	18.81	26.34	0.63	1.25	0.00	3.14	0.00
pituitary gland - adult, donor10196	10180-103C9	589.88	61.72	44.52	10.12	20.24	3.04	0.00	5.06	4.05	0.00
pituitary gland, adult, donor10252	10162-103A9	702.03	59.41	45.34	5.21	17.72	2.08	1.56	5.73	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	555.01	40.01	40.86	4.26	25.54	1.70	0.00	2.55	0.85	0.85
placenta, adult, pool1	10021-101D3	264.35	18.06	11.61	10.21	6.24	1.29	1.83	1.40	0.22	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	94.55	5.43	3.05	2.52	2.52	0.53	0.13	0.53	0.00	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	205.76	11.52	5.91	1.09	4.05	0.47	0.47	0.78	0.62	1.09
pons, adult, pool1	10033-101E6	398.75	31.33	32.36	17.30	24.62	1.12	0.95	1.29	0.60	0.09
postcentral gyrus, adult, pool1	10032-101E5	426.55	37.66	35.57	36.35	15.60	0.96	0.61	0.78	0.87	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	445.47	12.55	12.55	14.64	27.19	0.00	0.00	0.00	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	220.32	5.51	11.02	0.00	11.02	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	140.83	11.74	0.00	11.74	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	103.13	6.85	3.64	5.39	2.18	0.29	0.15	0.29	0.15	0.15
prostate cancer cell line:PC-3	10439-106E7	95.47	5.81	2.90	1.45	1.27	0.54	0.00	0.36	0.18	0.54
prostate, adult, pool1	10022-101D4	206.87	12.33	8.98	5.17	8.07	1.09	2.00	0.73	0.18	0.00
putamen, adult, donor10196	10176-103C5	412.64	39.89	27.15	40.60	17.70	1.65	0.71	3.07	1.65	0.00
putamen, adult, donor10252	10152-102I8	423.52	39.21	23.53	31.37	13.73	1.96	1.96	1.96	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	125.67	19.67	7.65	25.13	15.30	0.00	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	281.48	30.44	19.57	43.25	16.67	2.17	1.21	4.11	1.69	0.00
putamen, newborn, donor10223	10365-105F5	147.68	20.24	9.75	19.49	7.50	0.75	1.50	3.75	0.75	5.25
rectal cancer cell line:TT1TKB	10469-106I1	199.87	15.42	5.24	3.49	2.33	0.87	1.16	0.29	0.00	1.75
rectum, fetal, donor1	10067-101I4	372.79	12.52	18.08	8.35	8.35	4.17	0.00	4.17	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	85.65	8.69	6.15	1.91	3.82	0.00	0.21	0.85	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	93.61	9.94	4.97	0.41	2.07	0.00	0.41	0.83	0.00	0.00
retina, adult, pool1	10030-101E3	236.17	22.07	14.51	6.26	11.73	0.80	0.10	0.70	0.70	0.10
retinoblastoma cell line:Y79	10475-106I7	100.28	11.43	5.72	3.90	3.64	0.26	0.00	0.00	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	80.04	6.64	3.93	2.34	1.72	0.37	0.12	0.12	0.12	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	81.27	7.87	5.62	1.97	0.28	0.28	0.00	0.00	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	83.36	5.30	6.06	0.76	0.76	0.76	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	92.26	3.72	2.75	4.21	2.10	1.13	0.32	0.49	0.16	0.00
salivary acinar cells, donor2	11772-123I8	113.04	6.06	6.33	5.78	2.62	1.38	1.24	1.10	0.14	0.00
salivary acinar cells, donor3	11773-123I9	133.07	4.63	5.30	3.97	3.31	0.00	0.00	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	316.29	29.74	18.30	10.30	12.58	0.57	1.14	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	81.87	3.37	3.71	3.88	3.20	0.25	0.67	0.08	0.17	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	78.52	3.29	5.29	3.06	2.35	0.47	0.00	0.24	0.12	0.00
seminal vesicle, adult	10201-103F3	320.09	11.64	16.93	14.81	14.81	7.41	1.59	2.12	9.52	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	90.37	4.86	2.19	0.97	2.19	0.49	0.00	1.46	0.97	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	138.15	10.32	8.81	2.01	5.79	0.25	0.50	0.50	1.51	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	94.33	4.01	10.04	4.01	6.02	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	211.02	24.98	8.46	3.09	2.69	0.13	0.40	1.07	1.21	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	140.70	10.39	3.76	9.73	2.65	0.44	0.44	0.11	0.22	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	61.03	3.35	1.16	1.42	1.16	0.00	0.13	0.13	0.39	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	86.54	2.13	7.09	4.26	7.80	1.42	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	106.02	5.16	4.56	2.52	9.12	0.84	1.56	0.84	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	131.66	2.01	6.03	2.01	4.02	0.00	0.00	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	244.27	6.79	6.79	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	151.49	8.84	9.47	6.31	3.16	0.63	0.63	3.79	1.89	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	210.79	19.01	9.01	5.34	5.00	1.67	0.33	1.67	0.67	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	324.98	24.27	12.92	5.67	5.67	0.95	0.63	1.58	1.26	3.47
small cell lung carcinoma cell line:DMS 144	10841-111E4	111.02	6.17	5.40	1.73	1.93	0.19	0.39	0.77	0.96	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	242.79	21.10	9.72	12.36	5.93	0.49	1.32	0.82	0.16	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	210.39	19.30	6.11	1.13	1.77	0.48	0.16	1.45	0.64	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	54.48	5.67	2.40	4.36	1.74	0.00	0.44	0.44	0.22	0.22
small intestine, adult, pool1	10024-101D6	235.78	9.91	5.49	12.18	7.17	1.79	1.79	1.07	0.24	0.00
small intestine, fetal, donor1	10064-101I1	199.51	11.55	7.13	8.11	3.69	0.74	0.25	1.47	1.47	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	244.65	18.98	8.72	4.10	5.13	5.13	1.03	2.56	1.54	0.51
smooth muscle, adult, pool1	10048-101G3	156.62	9.30	4.91	3.62	7.24	0.78	0.78	0.52	1.29	0.00
somatostatinoma cell line:QGP-1	10781-110G7	179.31	4.56	4.02	3.22	7.50	0.00	0.00	0.00	0.54	0.54
spinal cord - adult, donor10196	10181-103D1	465.92	40.15	41.06	9.18	14.22	2.52	0.69	2.52	2.75	0.00
spinal cord, adult, donor10252	10159-103A6	451.05	38.64	26.02	4.34	15.38	1.58	1.97	1.18	1.18	0.00
spinal cord, adult, donor10258	10369-105F9	249.05	53.27	16.60	7.61	13.14	1.38	1.38	1.38	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	481.16	45.13	51.84	14.64	17.69	1.83	0.61	7.32	3.66	0.61
spinal cord, newborn, donor10223	10359-105E8	196.54	23.42	15.15	4.13	5.97	2.76	0.46	3.67	1.38	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	89.46	4.93	5.08	1.94	1.34	0.00	0.00	0.15	0.30	0.00
spleen, adult, pool1	10025-101D7	214.98	7.82	3.74	3.08	7.82	0.88	3.52	0.44	0.22	0.00
spleen, fetal, pool1	10044-101F8	162.41	8.90	3.65	1.75	4.05	0.16	0.32	0.24	0.24	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	85.81	4.66	2.48	3.31	1.14	0.10	0.10	0.52	0.21	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	87.15	7.78	2.47	5.70	1.14	0.19	0.00	0.00	0.57	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	98.20	6.99	5.59	6.29	3.49	0.35	0.00	2.10	1.75	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	55.12	3.91	1.95	1.56	1.95	0.39	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	99.95	5.40	2.25	17.33	2.14	0.45	0.11	0.34	0.23	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	83.87	8.90	2.12	3.81	1.27	0.42	0.85	0.85	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	127.77	6.35	2.54	2.12	1.27	0.85	0.00	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	438.94	4.27	18.16	9.61	12.82	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	328.71	14.81	9.11	8.55	14.24	2.85	1.14	2.85	3.42	0.00
substantia nigra - adult, donor10196	10178-103C7	705.56	162.82	54.27	54.27	0.00	0.00	0.00	108.55	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	421.44	31.78	16.82	4.36	14.75	1.87	2.49	1.87	0.62	0.00
substantia nigra, adult, donor10258	10371-105G2	450.53	46.04	33.62	20.69	33.62	3.10	0.52	0.52	3.10	0.00
substantia nigra, newborn, donor10223	10358-105E7	245.89	21.20	19.78	8.48	9.19	0.71	1.41	2.12	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	67.40	5.50	3.44	2.29	2.75	0.00	0.00	0.00	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	388.25	34.84	28.31	35.18	16.87	1.61	1.02	1.78	0.51	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	519.96	34.90	26.35	19.94	22.08	0.71	0.00	3.56	3.56	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	301.52	28.57	26.37	16.70	11.87	0.00	1.76	3.96	0.44	0.00
tenocyte, donor1	11763-123H8	82.39	5.59	5.93	1.75	0.70	1.05	0.35	0.70	0.00	0.00
tenocyte, donor2	11765-123I1	84.69	5.72	5.34	0.76	3.82	0.76	0.38	2.29	1.14	0.00
tenocyte, donor3	11768-123I4	60.42	4.82	1.85	1.48	1.11	0.37	0.00	1.11	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	113.70	7.99	6.80	2.72	1.02	0.51	0.17	0.51	0.68	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	102.66	8.48	4.78	2.31	0.77	0.92	0.62	0.15	0.46	0.62
teratocarcinoma cell line:PA-1	10807-111A6	169.08	8.06	6.97	2.79	1.55	0.62	0.46	0.31	0.46	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	190.29	5.08	5.71	3.81	3.05	0.89	1.27	0.38	0.51	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	72.61	2.27	5.67	1.89	1.51	0.38	0.38	0.76	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	105.90	2.40	1.64	1.53	1.20	0.65	0.22	0.11	0.00	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	43.32	7.17	4.56	1.95	1.95	0.65	0.00	1.95	0.65	0.00
testis, adult, pool1	10026-101D8	214.42	12.78	12.56	9.23	8.38	5.48	8.80	1.29	0.97	3.54
testis, adult, pool2	10096-102C6	181.79	9.47	13.08	15.79	15.34	2.71	0.45	1.80	1.80	7.67
thalamus - adult, donor10196	10168-103B6	473.61	56.30	24.29	18.77	34.22	3.31	1.10	3.31	2.21	0.00
thalamus, adult, donor10252	10154-103A1	337.10	30.63	17.03	9.38	13.75	1.56	0.78	1.88	1.25	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	206.31	80.06	53.89	7.70	67.74	4.62	3.08	3.08	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	429.35	37.71	37.71	13.34	27.34	2.96	0.99	2.96	1.15	0.00
thalamus, newborn, donor10223	10366-105F6	243.36	26.46	23.01	24.74	13.23	1.15	0.58	1.73	1.15	1.15
throat, adult	10209-103G2	151.30	10.24	6.74	3.00	7.99	0.50	0.50	2.50	0.50	0.00
throat, fetal, donor1	10061-101H7	247.73	16.76	13.71	6.09	8.53	0.30	0.30	1.83	1.52	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	99.37	7.15	4.97	5.17	2.19	0.00	0.00	0.20	0.40	0.00
thymus, adult, pool1	10027-101D9	418.14	17.10	4.57	6.16	11.04	3.08	6.66	1.19	0.30	0.30
thymus, fetal, pool1	10043-101F7	437.33	21.30	5.92	4.36	11.01	1.45	2.70	0.73	0.21	1.56
thyroid carcinoma cell line:KHM-5M	10776-110G2	69.94	3.59	2.53	0.93	2.13	0.66	0.27	0.27	0.00	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	91.78	5.31	4.05	2.24	1.82	0.28	0.14	0.14	0.14	0.56
thyroid, adult, pool1	10028-101E1	336.86	31.73	20.62	6.16	6.72	2.24	2.71	1.31	0.19	0.00
thyroid, fetal, donor1	10060-101H6	342.23	27.68	20.57	14.50	10.81	1.85	0.79	2.37	1.32	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	172.46	6.16	3.08	3.08	9.24	0.00	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	103.03	7.68	3.02	3.26	6.74	0.93	0.93	1.86	0.47	0.00
tongue, fetal, donor1	10059-101H5	230.15	11.03	11.03	5.52	10.64	0.79	1.97	0.39	1.58	0.00
tonsil, adult, pool1	10047-101G2	244.83	12.02	4.31	6.51	8.01	0.50	0.40	0.40	0.30	0.60
trachea, adult, pool1	10029-101E2	206.79	12.43	7.93	6.95	6.79	1.39	2.21	0.33	0.16	1.23
trachea, fetal, donor1	10058-101H4	256.21	11.93	8.85	5.39	10.39	2.31	1.54	1.15	2.69	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	88.92	4.96	3.54	1.42	0.71	0.00	0.35	0.71	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	84.70	5.78	3.95	3.34	2.63	0.41	0.20	0.20	0.30	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	60.64	4.07	5.17	2.19	0.16	1.10	1.25	0.16	0.31	0.47
tridermal teratoma cell line:HGRT	10694-109G1	70.39	1.90	1.90	1.90	1.90	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	83.38	4.32	2.54	3.22	1.02	0.17	0.25	0.08	0.17	0.00
umbilical cord, fetal, donor1	10057-101H3	121.02	4.17	12.52	2.09	8.35	0.00	0.00	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	203.90	16.72	8.53	3.58	8.02	0.68	0.51	0.85	0.17	0.00
uterus, fetal, donor1	10055-101H1	198.12	11.26	5.12	2.56	5.63	1.54	0.51	0.51	0.00	0.00
vagina, adult	10204-103F6	259.77	5.82	9.05	0.65	5.82	2.58	0.65	0.65	0.00	0.00
vein, adult	10191-103E2	251.42	9.86	7.89	7.23	8.55	1.53	1.53	1.97	1.10	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	44.33	3.20	1.60	1.87	0.80	0.00	0.53	0.27	0.27	0.27